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Abstract
Rates of obesity and type 2 diabetes in Canadian children and adolescents have increased 
rapidly in recent years, so research exploring modifiable risk factors is critical. Partial sleep loss 
has been linked with deteriorations in indicators of cardio-metabolic health. The objectives of 
this study were 1) to examine associations among short sleep duration and indicators of cardio- 
metabolic disease in Canadian children and adolescents, and 2) to identify determinants of short 
sleep duration. Using the 2007-2009 Canadian Health Measures Survey dataset as a data source, 
logistic regression models were developed to examine associations among sleep duration and 
indicators of cardio-metabolic disease and to identify predictors of short sleep duration. Short 
sleep duration was linked with greater odds of overweight/obesity in boys and adolescents only. 
Age was a strong predictor of inadequate sleep duration. Interventions designed to address sleep 
loss should focus on adolescents.
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Associations Between Sleep Duration and Indicators of Cardio-Metabolic Disease 
in Canadian Children and Adolescents 
Chapter 1: Introduction
A large body of research has demonstrated that short sleep duration is linked to indicators 
of cardio-metabolic disease, including overweight/obesity (OWOB), hyperinsulinemia and 
dyslipidemia (Knutson, 2010; Knutson, Spiegel, Penev, & Van Cauter, 2007). However, the 
majority of these studies focused on adults. Only a single study examining associations between 
sleep duration and OWOB has been conducted with Canadian children (Chaput, Brunet, & 
Tremblay, 2006), and that study was not nationally representative. No studies have explored 
associations between sleep duration and OWOB in Canadian adolescents. Additionally, 
although a number of studies have examined associations between sleep duration and OWOB, 
fewer studies have examined links among sleep duration and other indicators of cardio-metabolic 
health.
To address these knowledge gaps, this study had two objectives, including 1) to develop 
nationally representative estimates for associations between sleep duration and a range of 
indicators of cardio-metabolic disease in Canadian children and adolescents aged 6-17, and 2) to 
identify determinants of short sleep duration in this population. This thesis begins with a review 
of the literature on sleep duration and cardio-metabolic health, including theories that explain the 
pathophysiology of linkages between sleep duration and cardio-metabolic disease, the role of 
covariates in these relationships, and a summary of research supporting the measures and 
methods selected for this research.
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Indicators of Cardio-Metabolic Disease in Children and Adolescents
Obesity, dyslipidemia, and impaired carbohydrate metabolism are strongly associated 
with increased risks for coronary artery disease, stroke, and type 2 diabetes (International 
Diabetes Federation, 2011). Increased rates of OWOB have been observed in Canadian children 
and adolescents in recent years. For example, between 1981 and 2009, the prevalence of OWOB 
in Canadian youth aged 15-19 increased from 14% to 31% in boys and from 14% to 25% in girls 
(Statistics Canada, 2010c). Similarly, cases of type 2 diabetes in youth were almost non-existent 
30 years ago but the prevalence has increased dramatically in recent years, especially among 
certain groups such as Aboriginal populations (Canadian Diabetes Association, 2012).
Trends reflecting the rising prevalence of indicators of cardio-metabolic disease in 
younger populations are concerning for a number of reasons. Firstly, the development of 
obesity, dyslipidemia, or impaired carbohydrate metabolism at a younger age increases the 
potential years of risk exposure, thereby lowering the age of potential disease onset, increasing 
years of morbidity over the lifespan, and reducing life expectancy. Further, children and 
adolescents who exhibit milder stages of cardio-metabolic risk factors tend to progress to more 
severe categories of risk over time. For example, overweight children are at high risk of 
advancing from overweight to obesity (Reilly et al., 2010), and youth with pre-hypertension tend 
to progress to adulthood hypertension (Tirosh et al., 2010). For these reasons, early intervention 
is beneficial. Despite significant research activity in this area, the prevalence of cardio- 
metabolic risk factors in children and youth has continued to rise. Further research is needed to 
develop strategies that can successfully address this health issue.
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Sleep Duration in Children and Adolescents
In addition to this rising prevalence of obesity and type 2 diabetes has been a trend of 
decreasing total sleep time in Canadian children and adolescents (Matricciani, Olds, & Petkov, 
2011). Based on an analysis of administrative data from 20 countries and 690,747 children and 
adolescents, Matricciani et al. (2011) determined that sleep duration declined by a median of 
0.75 min/year between 1905-2008, for a total decline of over one hour during the last century. 
Declines in sleep duration were larger for older children (median -0.41 min per day per year for 
early primary school children to -0.91 min per day per year for older adolescents). Analysis by 
time period indicated that median sleep time increased from 1900-1939 (+2.57 min/day/year), 
but declined thereafter (-0.78 min/day/year from 1940-1969, -0.35 min/day/year from 1970- 
1989 and -0.40 min/day/year from 1990-2008). Sex-based analyses indicated that boys had 
larger declines in sleep duration (median -0.77 min/day/year) compared to girls (median, -0.67 
min/day/year). Sleep duration decreased most on school days (-0.74 min/day/year) compared to 
non-school days (-0.30 min/day/year). In Canadian children and adolescents specifically, there 
was a median decline of 1.10 min/day/year over the study period. These findings from the 
Canadian data were similar to rates in the USA (-1.14 min/day/year) and Europe (-1.17 
min/day/year), but contrasted with increases observed in Scandinavia (+0.65 min/day/year), 
Australia (+0.40 min/day/year), and the UK (+0.57 min/day/year).
Declining sleep time in children and adolescents has been attributed to various aspects of 
modem society (Matricciani et al., 2011). For example, the introduction of electricity and 
corresponding exposure to artificial light has been proposed as a plausible mechanism for 
extended waking hours (Gangwisch, Malaspina, Boden-Albala, & Heymsfield, 2005). A rapid 
expansion in use of technology has also been identified as a culprit for sleep loss among children
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and adolescents, including television, internet, and mobile phone usage, all of which are 
increasingly available in the bedroom (Taheri, 2006).
Canadian adults also report sacrificing sleep time in order to meet the demands of 
modem society (C. Williams, 2001). A 2005 Canadian study found that sleep loss in adults was 
related to long working hours, family obligations, long commuting times, and feeling time- 
stressed (Hurst, 2008). Fifty percent of Canadian adults report that they restrict their sleep to 
gain more time during the day when daily demands become heavy (Hurst, 2008). Sleep quality 
has also been affected by modem life: Canadians report that shift work and lack of physical 
exercise are linked with decreased sleep quality (Hurst, 2008). In order to compensate for week- 
night sleep loss, Canadian adults report sleeping in on the weekends (Hurst, 2008).
Although the function of sleep is not entirely understood, clues have emerged through the 
examination of what happens when people do not get enough sleep. Medical guidelines for 
human sleep requirements are informed by the number of hours of sleep needed to feel refreshed 
(National Sleep Foundation, 2012). While to some degree, sleep requirements vary from 
individual to individual, most adults require between 7-9 hours of sleep (National Sleep 
Foundation, 201 lb). In children and youth, sleep requirements vary substantially by 
developmental stage. Children aged 5-12 require about 10 hours of sleep per day, while 
adolescents need nine hours (Table 1). Researchers have examined the consequences of acute 
sleep loss occurring over several days, as well as chronic sleep loss occurring over longer periods 
such as weeks, months, or years.
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Table 1
Sleep Requirements Across the Lifespan (National Sleep Foundation, 2011a)
Age group Recommended sleep duration
0-2 months* 10.5-18.5 hours
2-12 months* 14-15 hours
18 months-3 years* 12-14 hours
3-5 years* 11-13 hours
5-12 years* 9-11 hours
13-19 years 8.5-9.5 hours
Adults 7-9 hours on average
Note. *Sleep time includes naps.
Sleep loss can also be categorized as partial or total. Partial sleep loss means getting 
fewer hours than needed to feel refreshed. In population-based research, people who chronically 
experience partial sleep loss can also be thought of as “short sleepers” or those with “short sleep 
duration”. Partial sleep loss has been linked to declines in human functioning and health. For 
example, acute periods of partial sleep loss are associated with declines in cognitive functioning 
(Pilcher & Huffcutt, 1996) and alterations in hormones involved in glucose regulation such as 
insulin and cortisol (Knutson et al., 2007). Given that long-term experimental studies examining 
partial sleep loss would be difficult due to ethical and methodological reasons, epidemiological 
studies have been conducted to explore the effects of chronic partial sleep loss. Findings from 
these population-based studies have also linked short sleep duration to poorer physical health 
(e.g., cardio-metabolic diseases) (Knutson, 2010) and declines in functioning (e.g., reaction time) 
(Pilcher & Huffcutt, 1996).
By comparison, total sleep deprivation during a period of time refers to a complete lack 
of sleep over that time frame. However, studies exploring the effects of total sleep deprivation in
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humans can only be conducted on a short term basis, because humans exhibit involuntary 
‘microsleeps’ after a few days of total sleep deprivation (Durmer & Dinges, 2005). 
Experimentally, these short periods of total sleep deprivation are associated with declines in 
mental, emotional, and physical health and functioning (Alhola & Polo-Kantola, 2007; Durmer 
& Dinges, 2005; Knutson et al., 2007; Pilcher & Huffcutt, 1996). For example, the results of a 
meta-analysis indicated that acute total sleep deprivation resulted in declines in cognitive 
function, including attention, processing speed, memory, and reasoning (Durmer & Dinges, 
2005). In a British study, a period of 17-19 hours without sleep induced declines in accuracy and 
response time comparable to measurements taken in people with a blood alcohol level of 0.05% 
(Williamson & Feyer, 2000). Short periods of total sleep deprivation have also been linked to 
deteriorations in indicators of cardio-metabolic health (Knutson, 2010) and immune function 
(Walsh etal., 2011).
Concurrent Trends of Cardio-Metabolic Disease and Decreasing Sleep Duration
Experimental and epidemiological lines of evidence suggest that the concurrent trends of 
increasing sleep restriction and rising rates of obesity and diabetes are not coincidental. 
Laboratory studies indicate that sleep restriction induces physiological and behavioural changes 
that negatively influence indicators of cardio-metabolic health. In the 1990’s, landmark 
experimental research demonstrated that sleep restriction (four hours sleep/night) over a period 
of six days could induce obesogenic changes in appetite- and weight-related hormones in healthy 
adults (Spiegel, Leproult, & Van Cauter, 1999). Hormone levels returned to baseline after a 
seven day period of sleep recovery (12 hours sleep/night) (Spiegel et al., 1999). Since then, a 
number of other experimental studies have similarly demonstrated that partial sleep loss can 
induce adverse endocrine changes (Buxton et al., 2012; Nedeltcheva, Kessler, Imperial, & Penev,
SLEEP DURATION AND CARDIO-METABOLIC INDICATORS 7
2009; Schmid, Hallschmid, Jauch-Chara, Bom, & Schultes, 2008; Spiegel, Tasali, Penev, & Van 
Cauter, 2004). Experimental studies also demonstrated that sleep restriction is related to 
obesogenic behaviours such as increased snacking (Nedeltcheva, Kilkus, et al., 2009) and 
decreased physical activity (Schmid et al., 2009). Reinforcing these findings are epidemiological 
studies indicating short sleepers are more likely to be overweight compared to longer sleepers 
(Cappuccio, Taggart, Kandala, & Currie, 2008; Chen, Beydoun, & Wang, 2008; Leproult & Van 
Cauter, 2010; Marshall, Glozier, & Grunstein, 2008) and exhibit other cardio-metabolic risk 
factors such as hypertension, dyslipidemia, and impaired carbohydrate metabolism (Ayas, White, 
Al-Delaimy, et al., 2003; Buxton et al., 2012; Buxton et al., 2010; Chaput, Despres, Bouchard, 
Astrup, & Tremblay, 2009; Flint et al., 2007; Gottlieb et al., 2005; Javaheri, Storfer-Isser, Rosen, 
& Redline, 2011).
Evidence suggests that a bi-directional relationship links short sleep duration to cardio- 
metabolic risk factors (Magee, Huang, Iverson, & Caputi, 2010). For example, carrying excess 
weight may adversely affect sleep quality; conversely, poor sleep quality could result in weight 
gain (Nieto, Surani, Huerta-Alardin, & Varon, 2006). Another example is sleep disordered 
breathing, a cause of sleep loss resulting from frequent interruptions in respiration during sleep 
(Nieto et al., 2006). Sleep disordered breathing is strongly associated with indicators of cardio- 
metabolic disease (Leinum, Dopp, & Morgan, 2009). It is thought that obesity plays a causal 
role in sleep disordered breathing because it frequently occurs among obese individuals, and 
weight loss can result in improvements in both sleep disordered breathing and cardio-metabolic 
health (Leinum et al., 2009). On the other hand, in studies that controlled for obesity, it was 
determined that sleep disordered breathing and concurrent sleep loss are independently 
associated with poorer cardio-metabolic health (Flint et al., 2007; Punjabi et al., 2004).
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Additionally, improvements in cardio-metabolic health have been demonstrated after treatment 
of sleep disordered breathing with continuous positive airway pressure (Dorkova, Petrasova, 
Molcanyiova, Popovnakova, & Tkacova, 2008) and tonsillectomy (Gozal, Capdevila, & 
Kheirandish-Gozal, 2008). Continuous positive airway pressure has not been demonstrated to 
result in weight loss (Redenius, Murphy, O'Neill, Al-Hamwi, & Zallek, 2008), suggesting that 
the pathophysiological mechanisms underlying the linkage between sleep disordered breathing 
and cardio-metabolic disease are at least partly attributable to factors other than obesity. In 
summary, although any relationship between cardio-metabolic risk factors and short sleep 
duration is likely bidirectional, the proposed study builds on the formidable body of evidence 
supporting short sleep duration as an etiological factor in poor cardio-metabolic health. Given 
that sleep duration could potentially be modifiable in many individuals, further research into 
sleep loss as a risk factor for cardio-metabolic disease is worthwhile.
The relationship between sleep duration and cardio-metabolic risk factors is complex. 
Similarly, any mechanisms that underlie these associations are potentially numerous. As such, 
the discussion provided in this literature review of potential mechanisms by which short sleep 
could influence indicators of cardio-metabolic disease is not intended to be comprehensive. 
Rather, this literature review focuses on the leading theories with the strongest supporting 
evidence.
Short Sleep Duration and Cardio-Metabolic Disease Outcomes
Based on data from longitudinal epidemiological studies, chronic short sleep duration 
predicts the future development of cardiovascular disease. Specifically, in a meta-analysis 
involving 15 prospective epidemiological studies with a total of 474,684 participants, short sleep 
duration at baseline was associated with a greater risk of developing or dying of coronary heart
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disease (relative risk=1.48) and stroke (relative risk=1.15) at the follow up time point 
(Cappuccio, Cooper, D'Elia, Strazzullo, & Miller, 2011). In a longitudinal study of 71,617 
female participants in the US-based Nurses’ Health Study, short sleep duration at baseline was 
associated with an increased risk of cardiovascular events 10 years later (relative risk=l .82 for 5 
or fewer hours/night) (Ayas, White, Manson, et al., 2003).
Short sleepers are also more likely to have type 2 diabetes and impaired carbohydrate 
metabolism. In a cross-sectional study of 1,486 adult participants in the American Sleep Heart 
Health Study, those sleeping five or fewer hours per night were 2.51 times more likely to have 
type 2 diabetes and 1.33 times more likely to have impaired glucose tolerance (Gottlieb et al., 
2005). In a longitudinal study, females who slept less than nine hours per night at baseline had a 
relative risk of 1.34 for developing symptomatic diabetes 10 years later (Ayas, White, Al- 
Delaimy, et al., 2003).
Short Sleep Duration and Overweight/Obesity
Obesity is a well-known risk factor for cardiovascular disease and diabetes (International 
Diabetes Federation, 2011), and the results of both laboratory experiments and population studies 
support a link between short sleep duration and obesity (Chen et al., 2008; Spiegel et al., 1999). 
So, short sleep duration also is related to early indicators that predict the future development of 
cardiovascular disease and diabetes.
Measuring overweight and obesity. Body mass index (BMI) is a frequently used 
measure of weight status in epidemiological research, and was used in this study. BMI is 
calculated by dividing mass (kg) by height (in metres squared). In adults, BMI categories 
include underweight (<18kg/m2), normal weight (18<25 kg/m2), overweight (25-30kg/m2), and 
obese (>30kg/m2) (World Health Organization, 1995). The development of these definitions was
SLEEP DURATION AND CARDIO-METABOLIC INDICATORS 10
informed by linking BMI scores to risks for morbidity and mortality (World Health 
Organization, 1995). In children and adolescents, BMI categories are developed using normative 
data (Cole, Bellizzi, Flegal, & Dietz, 2000). This study used the BMI categorization system 
developed by Cole et al. (2000) which is based on international normative data standardized for 
age and sex. BMI categories used in this research include obese, overweight, or neither (Cole et 
al., 2000).
Although measures of fat distribution such as waist circumference and waist-hip ratio 
have also received significant attention, many studies suggest that these measures offer no 
advantage over BMI for predicting cardio-metabolic risk in children and adolescents (Garnett, 
Baur, Srinivasan, Lee, & Cowell, 2007; Johnson et al., 2010; Qiao & Nyamdoij, 2010; Vazquez, 
Duval, Jacobs, & Silventoinen, 2007; Ying, Song, Zhao, & Jiang, 2010). Additionally, because 
norms for body mass vary with age and gender in growing children and adolescents, 
standardized BMI scores must be used to account for this in epidemiological studies (Knutson,
2005). Because more research is available to support age- and sex- standardized percentiles for 
BMI compared to similarly standardized measures of adiposity (Cole et al., 2000), BMI was 
selected as the preferred measure for this study.
Energy imbalance theory of obesity. The energy imbalance theory of obesity can be 
used to explain the mechanisms that underlie the observed connections between short sleep 
duration and obesity. For weight gain to occur, an imbalance between energy intake and energy 
expenditure must exist (Chaput, Klingenberg, & Sjodin, 2010). Food consumption is mediated 
homeostatically (i.e., through perceived sensations of appetite/hunger) as well as through 
hedonic, or pleasure-based eating behaviour (Chaput, Klingenberg, & Sjodin, 2010). Energy 
expenditure can occur voluntarily through physical activity or involuntarily through basal
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metabolism and thermogenesis (Chaput, Klingenberg, & Sjodin, 2010). Short sleep duration 
could cause weight gain through both sides of this energy balance equation (Chaput, Klinenberg, 
and Sjodin, 2010).
Short sleep duration dysregulates homeostatically mediated energy intake.
Homeostatic control over appetite is orchestrated through complex interactions among many 
neuroendocrine hormones (Morselli, Leproult, Balbo, & Spiegel, 2010). Key hormones thought 
to be involved in the sleep-obesity relationship include leptin, ghrelin, insulin, and cortisol 
(Morselli et al., 2010). Leptin and ghrelin have opposite functions in regulating appetite (Pocock 
& Richards, 2006). Leptin is released from fat cells and is thought to suppress appetite, while 
ghrelin is secreted from the stomach, and stimulates hunger (Pocock & Richards, 2006). Insulin 
plays an important role in the regulation of blood glucose levels (Pocock & Richards, 2006). 
When blood glucose levels rise, insulin is secreted by the pancreas and glucose is transported out 
of the blood and into the cells (Pocock & Richards, 2006). Cortisol is part of the body’s stress 
response and results in increased arousal, elevations in blood glucose, and suppression of the 
immune system (Pocock & Richards, 2006).
Experimental studies have demonstrated that partial sleep loss disrupts levels of leptin, 
ghrelin, cortisol, and insulin (Nedeltcheva, Kessler, et al., 2009; Schmid et al., 2008; Spiegel, 
Leproult, et al., 2004; Spiegel, Tasali, et al., 2004). For example, in healthy young men, when 
sleep time was restricted to four hours sleep/night in bed over two days, participants exhibited an 
18% decrease in leptin and a 28% increase in ghrelin compared to when they spent 10 hours in 
bed over two days (Spiegel, Tasali, et al., 2004). Participants also experienced a 24% increase in 
hunger after the period of sleep loss, with larger increases in appetite for high carbohydrate foods 
(Spiegel, Tasali, et al., 2004). Similar findings were demonstrated by Schmid et al. (2008), with
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a single night of partial sleep loss resulting in elevations in both ghrelin and sensations of 
hunger.
Increased waking time = increased eating time. Initially, the idea that sleep loss could 
cause obesity may seem non-intuitive because sleep is a sedentary act, and having more time 
awake could provide more time for energy expenditure. Interestingly, research suggests that the 
opposite is true. In modem societies, people tend to consume more calories than they expend 
(Chaput, Klingenberg, Astrup, & Sjodin, 2010). In other words, spending more time awake 
tends to worsen the energy imbalance that underlies obesity because people tend to 
overcompensate for any increased energy expenditure that occurs during the additional hours 
spent awake (Chaput, Klingenberg, Astrup, et al., 2010). This observed increase in energy intake 
resulting from sleep loss may be a consequence of increased appetite as well as non-appetite- 
based eating behaviour (Chaput, Klingenberg, Astrup, et al., 2010).
Several aspects of modem lifestyles have been shown to stimulate non-appetite mediated 
food consumption (Chaput, Klingenberg, & Sjodin, 2010). Modem lifestyles facilitate obesity 
through the combination of easy access to calorie-dense foods and frequent engagement in 
sedentary activities that are associated with eating (Chaput, Klingenberg, Astrup, et al., 2010). 
Thus short sleep (i.e., increased time awake) translates to increased exposure to the obesogenic 
modem environment. While it is intuitive that sedentary activities such as television watching 
and computer use are associated with reduced energy expenditure, research also suggests that 
these activities also result in increased food consumption independent of appetite (Chaput, 
Klingenberg, & Sjodin, 2010). Many sedentary activities are thought to result in increased 
calorie intake due to disconnection from internal satiety signals, reducing conscious control over 
food consumption, and exposure to food-related advertising (Chaput, Klingenberg, Astrup, et al.,
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2010). For example, Blass et al. (2006) found that meals consisting of macaroni and cheese or 
pizza consumed over a 30 minute period of television watching resulted in an additional 288 kcal 
consumed compared to meals consumed while not watching television. Similar findings have 
been demonstrated with increased food consumption during meals consumed after video game 
playing (+80 kcal) (Chaput, Klingenberg, Astrup, et al., 2010), and after cognitive working such 
as reading and writing (+229 kcal) (Chaput, Klingenberg, Astrup, et al., 2010; McCann,
Wamick, & Knopp, 1990). Listening to music while eating has also been associated with 
increased calorie consumption (+107 kcal) (Stroebele & de Castro, 2006).
Non-appetite mediated eating behaviour also links short sleep duration to obesity. In a 
crossover study of 11 healthy participants, eating behaviour was compared between a sleep 
restriction condition (5.5 hours of sleep/night for 14 days) and an adequate sleep condition (8.5 
hours of sleep/night for 14 days) (Nedeltcheva, Kilkus, et al., 2009). While sleep restriction did 
not affect leptin or ghrelin levels in study participants, increased calorie consumption was 
observed. Additionally, energy expenditure did not increase to compensate for the increased 
energy intake. Interestingly, while energy consumption during meals was similar in both 
conditions, increased snacking behaviour was observed during the sleep restriction period, 
especially during times when study participants would normally be sleeping. Several other 
studies have confirmed this finding that partial sleep loss is followed by increased calorie 
consumption (Brondel, Romer, Nougues, Touyarou, & Davenne, 2010; Hicks, McTighe, & 
Juarez, 1986).
Short sleepers may also eat more in an attempt to offset fatigue associated with sleep 
debt. Short sleepers frequently report fatigue and daytime sleepiness (Durmer & Dinges, 2005)
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and it has been hypothesized that sleep restricted individuals might increase calorie intake in an 
attempt to counteract the fatigue associated with sleep loss (Magee et al., 2010).
Short sleep duration reduces voluntary energy expenditure. Sleep restriction may also 
contribute to the other side of the energy balance equation through decreased energy expenditure. 
Energy expenditure occurs both voluntarily (e.g., through physical activity), and non-voluntarily 
(e.g., to power basic metabolic processes). Fatigue consequent to sleep restriction could result in 
reduced motivation to participate in vigorous physical activity (Magee et al., 2010). Schmid et 
al. (2009) found that after two nights of sleep loss (four hours of sleep/night), physical activity 
was reduced in healthy men dining free-living conditions.
Short sleep duration reduces involuntary energy expenditure. Involuntary energy 
expenditure occurs to support basic metabolic processes, to maintain body temperature, and in 
the disposal of excess energy intake (Tan, Manchester, Fuentes-Broto, Paredes, & Reiter, 2011). 
Although research in this area is sparse, it has also been hypothesized that sleep duration could 
affect involuntary energy expenditure (Taheri, 2006). Melatonin plays an important role in the 
regulation of involuntary energy expenditure (Tan et al., 2011). As such, the suppression of 
melatonin due to late night light exposure is another proposed mechanism that could explain the 
linkages between sleep loss and obesity (Reiter et al., 2011).
Melatonin also could influence involuntary energy expenditure via the growth and 
activity of brown adipose tissue. The human body contains two types of fat: white adipose tissue 
and brown adipose tissue (Pocock & Richards, 2006). While the function of white adipose tissue 
is energy storage and padding (Martini, Timmons, & Tallitsch, 2006), brown adipose tissue is 
metabolically active (Pocock & Richards, 2006). Brown adipose tissue is thought to have 
several roles in human physiology, including heat generation to maintain body temperature (i.e.,
SLEEP DURATION AND CARDIO-METABOLIC INDICATORS 15
non-shivering thermogenesis) (Pocock & Richards, 2006) and maintenance of energy balance by 
disposing of excess energy intake through heat production (i.e., diet-induced thermogenesis) 
(Tan et al., 2011). Through these mechanisms, brown adipose tissue bums energy and reduces 
white adipose tissue stores (Tan et al., 2011). In animals, melatonin stimulates the activity and 
growth of brown adipose tissue (Tan et al., 2011). As such, it is possible that melatonin 
suppression linked with late night light exposure could result in decreased energy expenditure 
and an increase in white adipose tissue reserves (Tan et al., 2011). In humans, melatonin 
administration has a hypothermic effect on core body temperature, but proportionally larger 
increases in peripheral body temperature and peripheral heat loss occur simultaneously (Tan et 
al., 2011). No studies thus far have examined the effect of sleep loss on brown adipose tissue 
activity in humans.
Epidemiological evidence for sleep-obesity link.
Review articles. Review articles report that a sizable body of research has explored the 
relationship between sleep duration and overweight/obesity in children and adults (Cappuccio et 
al., 2008; Chen et al., 2008; Marshall et al., 2008; Patel & Hu, 2008). Meta-analyses of 
epidemiological studies involving children and adolescents observed a significantly increased 
risk of OWOB in short sleepers compared to longer sleepers (Cappuccio et al., 2008; Chen et al., 
2008). For example, in a meta-analysis of 13 studies involving 30,002 children and adolescents 
aged 2-20 years, short sleepers had a pooled odds ratio of 1.89 for obesity (Cappuccio et al., 
2008). Similarly, in a systematic review of 11 studies, youth falling into the shortest-duration 
category of sleepers had an odds ratio of 1.92 for being OWOB compared to the longest sleepers 
(Chen et al., 2008).
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Cross-sectional studies -  adults. The majority of cross-sectional studies involving adults 
have demonstrated either a ‘U’ shaped or negative linear association between sleep duration and 
OWOB (Patel & Hu, 2008), with the lowest risk of OWOB occurring in adults who achieve 7-9 
hours of sleep/night (Singh, Drake, Roehrs, Hudgel, & Roth, 2005; Taheri, Lin, Austin, Young,
& Mignot, 2004). While some cross-sectional studies on adults have found no association 
between sleep duration and obesity (e.g., Gottlieb et al., 2005), the results of age-stratified 
analyses demonstrate that the relationship is more consistent in younger adults (Gangwisch et al.,
2005).
The only Canadian research examining the relationship between sleep duration and 
OWOB in adults is by Chaput and colleagues in Quebec (2007). In a study of 714 adults, 
participants who slept 5-6 hours/night had an odds ratio of OWOB of 1.38 compared to those 
who slept 7-8 hours per night. Participants sleeping 5-6 hours/night also had higher adiposity 
and lower leptin levels. These Canadian data are supported by international studies. In a cohort 
study of 8,073 people, initial cross-sectional analyses determined that short sleepers had an 
increased risk of obesity compared to longer sleepers (Gangwisch et al., 2005).
Cross-sectional studies — children and adolescents. The results of cross-sectional 
research examining the association between sleep duration and OWOB in children and 
adolescent populations are more consistent than findings in adults (Chen et al., 2008; Patel & Hu, 
2008). The only pediatric obesity-sleep research study that has been completed in Canada is the 
‘Quebec en Forme’ project which involved 422 Quebec children aged 5-10 years (Chaput et al.,
2006). After adjusting for age, sex, and obesity risk factors, a negative linear relationship was 
observed between OWOB and sleep duration (Chaput et al., 2006). Compared to children
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sleeping 12-13 hours/night, odds ratios for OWOB were 1.42 for those with 10.5-11.5 hours of 
sleep/night and 3.45 for those with 8-10 hours of sleep/night.
Cross-sectional studies from other countries support these findings from Quebec. In an 
Australian study, Eisenmann and colleagues (2006) studied the relationship between sleep 
duration, waist circumference, and BMI in 6,324 youth aged 7-15. Compared to youth who slept 
more than 10 hours/night, youth who slept less than eight hours/night had an odds ratio for 
OWOB of 3.1. In a cross-sectional study of 4,486 adolescent participants in the US National 
Longitudinal Study of Adolescent Health, Knutson (2005) identified a negative relationship 
between sleep duration and BMI in males only. While many of these large population-based 
studies used self-reported measures of sleep duration, smaller studies using objective measures 
of sleep duration such as actigraphy also support these findings, providing even stronger 
evidence for the obesity-sleep duration relationship (Beebe et al., 2007; Gupta, Mueller, Chan, & 
Meininger, 2002).
Longitudinal studies -  adults. Similar to the results of cross-sectional research, 
longitudinal studies in adults tend to reveal a U-shaped or negative linear association between 
sleep duration and overweight. In a longitudinal study of 276 Canadian adults, those who slept 
5-6 hours/night were 35% more likely to gain weight over a six year period compared to those 
who slept 7-8 hours/night (Chaput, Despres, Bouchard, & Tremblay, 2008). The risk of 
becoming overweight over the six year period was 27% higher in short sleepers compared to 
those sleeping 7-8 hours/night (Chaput et al., 2008). In a retrospective analysis of 68,183 
women in the US Nurses’ Health Study, Patel et al. (2006) found that after adjusting for age, the 
shortest sleepers (<5 hours of sleep/night) weighed the most at every future time point. While all 
women in the study tended to gain weight over time, a dose-response relationship between sleep
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duration and weight gain was demonstrated: fewer hours of sleep per night were associated with 
larger weight gain four and 10 years later (Patel et al., 2006). In a prospective cohort study of 
496 young American adults, Hasler et al. (2004) found a negative relationship between sleep 
duration and weight gain between ages 27 and 40. Another US-based prospective cohort study 
of 8,073 participants demonstrated that each additional hour of sleep at baseline was negatively 
associated with weight gain over the study period (Gangwisch et al., 2005).
Longitudinal studies — children and adolescents. Compared to studies on adults, fewer 
longitudinal studies have been conducted on children and adolescents, and none have been 
conducted in Canada. In a British study, Reilly et al. (2005) studied 8,234 seven-year-old 
children over four years; short sleep duration predicted higher BMI at follow-up (odds 
ratio=l .45). Similar associations have been observed in studies undertaken in the USA with 
2,281 children aged 3-12 years over a 5 year period (Snell, Adam, & Duncan, 2007) as well as 9- 
year olds over 4.5 years (Agras, Hammer, McNicholas, & Kraemer, 2004). A long term 
prospective New Zealand cohort study had similar results: short sleep in childhood predicted 
higher BMI at age 32 (Landhuis, Poulton, Welch, & Hancox, 2008).
Obesity is only one of several established risk factors for cardiovascular disease and 
diabetes. While a substantial body of literature has explored short sleep duration as a risk factor 
for obesity, fewer studies have examined connections among sleep loss and other early indicators 
of cardio-metabolic disease such as impaired carbohydrate metabolism, low HDL cholesterol, or 
elevated triglycerides.
Short Sleep Duration and Impaired Carbohydrate Metabolism
Dysregulation of carbohydrate metabolism is thought, at least in part, to mediate the 
relationship between obesity and cardio-metabolic disease (Kahn & Flier, 2000). Dysregulation
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of carbohydrate metabolism may be an even more sensitive predictor of cardio-metabolic disease 
than is obesity (Bacha, Saad, Gungor, & Arslanian, 2006). The body maintains blood glucose 
levels within a narrow range to avoid the life threatening consequences of hypoglycemia and 
hyperglycemia (Pocock & Richards, 2006). While type 2 diabetes is diagnosed by elevated 
blood glucose levels, hyperglycemia is the end result of progressive deteriorations in insulin 
sensitivity and insulin secretion (Cali & Caprio, 2008). Deteriorations in insulin sensitivity are 
frequently accompanied by elevations in insulin levels, or hyperinsulinemia (Kim & Reaven, 
2008). The presence of hyperinsulinemia provides early information about future risk of 
developing diabetes as well as cardio-metabolic disease in later life (Nguyen et al., 2010).
Sleep loss could influence dysregulation of carbohydrate metabolism through increases in 
obesity, sympathetic nervous system activity, evening cortisol and growth hormone, and 
decreased glucose uptake (Knutson, 2010). While the increased adiposity associated with obesity 
induces impairments in carbohydrate metabolism (Kahn & Flier, 2000), sleep loss also impairs 
carbohydrate metabolism independent of obesity (Flint et al., 2007; Spiegel et al., 1999). 
Consequences of partial sleep loss include reduced brain glucose utilization as well as increases 
in growth hormone and evening cortisol, both of which result in impaired carbohydrate 
metabolism (Knutson, 2010). In addition, sleep restriction induces insulin resistance (Buxton et 
al., 2012; Nedeltcheva, Kessler, et al., 2009) and may also result in increased sympathetic 
nervous activity which results in reduced insulin secretion (Knutson, 2010).
Experimental studies have demonstrated that acute, partial sleep loss can have a negative 
influence on carbohydrate metabolism (Spiegel et al., 1999), and population-based studies 
indicate that short sleep duration is associated with future risk of diabetes (Spiegel, Knutson, 
Leproult, Tasali, & Van Cauter, 2005; Spiegel, Tasali, Leproult, & Van Cauter, 2009). There are
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a number of potential explanations for these observed linkages between sleep loss and impaired 
carbohydrate metabolism. Firstly, a consequence of sleep loss is increased secretion of growth 
hormone and cortisol as well as circulating pro-inflammatory cytokines, all of which reduce 
insulin sensitivity (Flint et al., 2007). Further, sleep restriction results in increased sympathetic 
nervous system activity, a state shown to inhibit pancreatic beta cell function and decrease 
insulin secretion (Flint et al., 2007). Finally, short sleepers are likely to be exposed to light at 
night and could subsequently exhibit suppression of melatonin secretion. In animal studies, 
administration of melatonin results in improvements in carbohydrate metabolism (Wolden- 
Hanson et al., 2000). Another explanation for the beneficial effect o f melatonin is that this 
hormone leads to improved sleep quality, which then leads to the observed improvements in 
metabolic parameters (Van Cauter, 1998). The deteriorations in carbohydrate metabolism 
resulting from sleep loss are also likely to have negative consequences for other cardio-metabolic 
risk factors such as dyslipidemia and hypertension (Ferrannini, 2006).
Experimental studies involving humans have demonstrated that impairments in 
carbohydrate metabolism could be induced by acute partial sleep deprivation. Spiegel, Leproult, 
and Van Cauter (1999) demonstrated that healthy young men restricted to four hours in bed per 
night over six nights had significant impairment in glucose metabolism, exhibiting measurements 
characteristic of older adults with impaired glucose tolerance. After a seven-day period of sleep 
recovery (12 hours in bed per night), glucose tolerance values returned to healthy ranges. A 
similar study that utilized a randomized crossover design to test the effect of sleep restriction 
(four hours in bed/night for two nights) vs. adequate sleep (10 hours in bed/night for two nights) 
had similar findings (Spiegel et al., 2005). More recent studies involving both men and women 
confirm the findings from these early studies. For example, Buxton et al. (2010) determined that
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a week-long period of sleep restriction (five hours of sleep/night) resulted in decreased glucose 
tolerance. In a study of 11 healthy men and women, Nedeltcheva et al. (2009) observed reduced 
glucose tolerance and reduced insulin sensitivity after a 14 day period of sleep restriction (5.5 
hours of sleep/night). In a study of nine healthy men and women, a single night of partial sleep 
loss (four hours of sleep/night) resulted in decreased insulin sensitivity (Donga et al., 2010). 
Likewise, in a study involving shift workers in the Antarctic, workers demonstrated decreased 
carbohydrate tolerance after meals consumed during night shifts (Lund, Arendt, Hampton, 
English, & Morgan, 2001). Carbohydrate tolerance returned to normal after two days of working 
day shifts (Lund et al., 2001).
Epidemiological research also supports a link between sleep loss and deteriorations in 
carbohydrate metabolism (Knutson, 2010). In a longitudinal study of 276 Canadian adults, 
Chaput, Despres, Bouchard, Astrup, and Tremblay (2009) determined that over the six year 
study period short sleepers had a relative risk of 2.78 for developing impaired glucose tolerance 
or diabetes compared to those who slept 7-8 hours/night. In an African-American population 
with type 2 diabetes, short sleepers had an increased severity of impaired glucose regulation 
(Knutson, Ryden, Mander, & Van Cauter, 2006).
Apparently, only a single study has examined links between carbohydrate metabolism 
and sleep duration in children or adolescents. In a laboratory study of 40 obese children and 
adolescents ages 3-18, participants who slept fewer than six hours per night had increased insulin 
resistance (Flint et al., 2007). No difference in obesity was observed between the shorter and 
longer sleepers, indicating that the relationship between short sleep and impaired carbohydrate 
metabolism was independent of obesity.
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Measuring Carbohydrate Metabolism. While the gold standard for assessing 
carbohydrate metabolism is the euglycemic clamp method, this procedure is not feasible for large 
population surveys because it is expensive, invasive, and time consuming (Chiarelli & 
Marcovecchio, 2008). Lower-cost and less invasive surrogate measures that have been validated 
in children and adolescents are based on simpler measures o f fasting insulin and/or glucose 
(Chiarelli & Marcovecchio, 2008). High fasting insulin in childhood and adolescence is strongly 
associated with cardio-metabolic risk factors such as obesity, hypertension and dyslipidemia 
(Bao, Srinivasan, & Berenson, 1996; Lambert et al., 2004; Nguyen et al., 2010). Because fasting 
insulin is convenient to measure and has strong associations with future cardio-metabolic 
disease, it was chosen to represent carbohydrate metabolism for this study.
Short Sleep Duration and High Triglycerides
Although elevated triglycerides are considered a marker of increased risk for 
cardiovascular disease (International Diabetes Federation, 2011), relatively few studies have 
examined associations between sleep duration and triglyceride levels. In a US-based cross- 
sectional study of 1,214 adult participants, Hall et al. (2008) found that short sleep duration was 
associated with elevated triglycerides. In a cross-sectional study of 8,860 Norwegian 
participants aged 40-45, short sleep duration, compared to longer sleep duration, was related to 
higher triglycerides (Bjorvatn et al., 2007). Given that shift workers frequently experience sleep 
loss, epidemiological examination of cardio-metabolic risk factors in shift workers provides 
additional insight. Shift workers exhibit higher triglycerides even after adjusting for 
socioeconomic factors (Karlsson, Knutsson, & Lindahl, 2001). During night shifts, workers 
have increased post-meal triglyceride levels compared to the same meal consumed during the 
day (Lund et al., 2001).
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Short Sleep Duration and Low HDL Cholesterol
Low HDL cholesterol is also linked to the future development of cardio-metabolic 
disease (International Diabetes Federation, 2011). Only a few epidemiological studies have 
examined relationships between sleep duration and lower HDL cholesterol. In a cross-sectional 
study of 8,860 Norwegian participants aged 40-45, short sleepers had lower HDL cholesterol 
compared to longer sleepers (Bjorvatn et al., 2007). In a prospective study involving 935 women 
from the Nurses’ Health Study, among women who had type 2 diabetes at baseline, short sleep 
duration was associated with decreased HDL cholesterol four years later (C. J. Williams, Hu, 
Patel, & Mantzoros, 2007).
Covariates Involved in the Sleep Duration/Cardio-Metabolic Disease Relationship
Covariates could influence the relationship between sleep duration and indicators of 
cardio-metabolic disease through confounding and/or interaction (Szklo & Nieto, 2007). In 
order to better estimate the potential causal influence of sleep duration on indicators of cardio- 
metabolic disease in this observational study, the influence of additional variables must be 
accounted for. In this study this was done by selecting covariates from available Canadian 
Health Measures Survey (CHMS) variables that were likely to have confounding and/or 
interaction effects, based on evidence from the literature.
Confounding occurs when an observed association between the predictor and outcome 
variables is the result of the influence of a third variable, or confounder (Szklo & Nieto, 2007). 
Confounding variables are related to both the predictor variable and the outcome variable (Szklo 
& Nieto, 2007). A confounding effect can be illustrated by using a fictitious example of an 
observed association between inadequate sleep duration and OWOB in a population. In this 
example, further exploration of the data reveals that increasing age is associated both with an
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increased risk of obesity and with inadequate sleep. As such, analyses must account for the 
confounding effect of age on the relationship between sleep duration and obesity. Inclusion of 
confounding variables in multivariate models is an effective method of adjusting for the effect of 
confounders on the relationship between a predictor variable and the outcome variable (Hosmer 
& Lemeshow, 2000; Szklo & Nieto, 2007).
Several techniques can be used to identify appropriate confounders to include in 
multivariate models. First, a clinical or scientific rationale should exist that supports the 
potential impact of confounders on both predictor and outcome variables (Szklo & Nieto, 2007). 
While significance testing has also been used as a method of searching for confounders, this 
method has been criticized because exhaustive searching is likely to uncover statistically 
significant but spurious associations (Pace, 2008). Additionally, sometimes a combination of 
variables, taken together, can have a confounding effect, while the individual variables do not 
(Hosmer & Lemeshow, 2000). A disadvantage of relying on clinical relevance alone to select 
variables is that the inclusion of too many variables can result in unstable estimates, or 
‘overfitting.’ This problem can be recognized through the appearance of large standard errors 
and/or unrealistic coefficients (Hosmer & Lemeshow, 2000). A final strategy to identify 
confounders is to add the potential confounding variable(s) to the bivariate model. If addition of 
the variable(s) results in a change in the direction and/or magnitude of the crude association, this 
is indicative of a confounding effect (Szklo & Nieto, 2007).
When the effect of a predictor variable on an outcome variable varies at different levels 
of a third variable, this is called ‘interaction’, ‘effect modification’, or ‘heterogeneity of effect’ 
(Hosmer & Lemeshow, 2000; Szklo & Nieto, 2007). For example, if  short sleep duration predicts 
obesity in boys but not girls, then it could be said that sex modifies the relationship between
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sleep duration and obesity. Interaction can be additive or multiplicative (Szklo & Nieto, 2007). 
In additive interaction, the difference observed for a main effect at different levels of a third 
variable is equal to the sum of the effects of the individual variables (Szklo & Nieto, 2007). In 
multiplicative interaction, a heterogeneous main effect is larger (synergistic) or smaller 
(antagonistic) than the individual effects of the predictor variable and the third variable together 
(Szklo & Nieto, 2007).
Several strategies exist to identify and address interactions in logistic regression models. 
To identify interactions, a list of scientifically plausible interactions is created (Hosmer & 
Lemeshow, 2000). Next, interaction terms are added to the main effects model one at a time and 
tested for significance (Hosmer & Lemeshow, 2000). Hosmer and Lemeshow (2000) suggest 
that interaction terms that are significant at p<0 .10 and add to the overall model fit (i.e., 
likelihood ratio test) should be included in the final model to adjust for their effect. Another 
strategy to address interactions in logistic regression models is to stratify analyses (Szklo & 
Nieto, 2007). Using interaction terms confers the advantage of a larger sample size when data 
are sparse (Szklo & Nieto, 2007).
Main Relationships of Interest. The following diagrams illustrate hypothesized 
relationships among the variables of interest in this study (Figure 1). As described in further 
detail in chapter 2, this study utilized logistic regression models to examine the hypothesized 
associations among the predictor variables and the outcome variables. Note that in each of the 
diagrams below, the relationship shown among the predictor variables and the dependent 
variables is illustrated with a uni-directional arrow. However, this observational, cross-sectional 
study’s limitations do not permit determination of the directionality of these associations, so the 
arrows are intended to describe only the hypothesized relationships of interest.
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A. Association between sleep duration and overweight/obesity.
Potential Confounders
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Dependent Variable
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B. Association between sleep duration and hyperinsulinemia.
Potential Confounders
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\
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Sleep duration Hyperinsulinemia
C. Association between sleep duration and low HDL cholesterol.
Potential Confounders
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Household incom e \
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Sleep duration Low HDL cholesterol
Figure 1. Main relationships of interest explored using logistic regression models.
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D. Association between sleep duration and high triglycerides.
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E. Predictors of sleep duration.
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Figure 1 (continued). Main relationships of interest explored using logistic regression models. 
Age. Age is likely to be a confounder in the relationship between sleep duration and
indicators of cardio-metabolic disease in children and adolescents. Progression through puberty
is associated with deteriorations in indicators of cardio-metabolic health (Lambert et al., 2004).
Hormonal changes that transpire during puberty arise concurrently with increases in body mass
and blood pressure as well as deteriorations in blood lipid levels and carbohydrate metabolism
(Lambert et al., 2004).
At the same time, epidemiological data suggest that sleep duration tends to decrease
through adolescence, outpacing decreases in developmentally appropriate sleep requirements
(Iglowstein, Jenni, Molinari, & Largo, 2003). For example, in a population of German youth,
age was the strongest predictor of sleep duration, explaining 57.0% and 41.2%, respectively, of
the variance in sleep length for girls and boys (Hitze et al., 2009). No Canadian study has
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examined age as a determinant of sleep duration in adolescents or children. Although it seems 
plausible that sleep requirements and sleep duration should be related not only to biological age 
but also to developmental stage because circadian rhythms are thought to vary with 
developmental stage (Wolfson, 2010), evidence does not support an association between pubertal 
stage and sleep duration (Flint et al., 2007). Thus, social factors seem to be important 
determinants of sleep duration. Age-related factors that influence sleep duration include altered 
physiological sleep requirements, social and cultural factors specific to adolescence, and 
advances in circadian rhythm phase that favour alertness later at night (Knutson, 2005).
It is also plausible that age could be an effect modifier in the relationship between sleep 
duration and cardio-metabolic disease (i.e., the associations among short sleep duration and 
indicators of cardio-metabolic disease might be stronger or weaker at different ages). One 
possible reason why this might occur is that older children with inadequate sleep may have been 
short sleepers since childhood. If this is the case, then adolescents with short sleep should have 
had a greater exposure time to the damaging effects of inadequate sleep, and then a relationship 
between short sleep and indicators of cardio-metabolic disease would only surface in older 
children, or be stronger in older children. Analyses were stratified by age to test for this effect.
Sex/gender. Sex and gender may also confound the relationship between sleep duration 
and cardio-metabolic disease because biological and social factors linked to sex and gender may 
influence both sleep duration and indicators of cardio-metabolic disease. Data from a recent 
Canadian health survey found that adolescent boys were more likely to be OWOB compared to 
girls (31% vs. 25%) (Statistics Canada, 2010c). The sex-specific hormone changes that occur 
during adolescence could have different effects on weight gain (Knutson, 2005). For example,
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while adolescent males exhibit increases in testosterone and muscle mass, adolescent females 
demonstrate increases in estrogen and fat tissue (Martini et al., 2006).
For adults, social factors mediate observed sex differences in sleep duration (Hurst,
2008), but for children the relationship between sex and sleep duration or quality is less well 
studied. There is no difference in total sleep time for adolescent girls versus adolescent boys, but 
females and males have different sleep patterns, with girls awaking earlier on weekdays and later 
on weekends compared to boys (Lee, McEnany, & Weekes, 1999). Sleep architecture also 
differs by sex, with females spending proportionally more time in the slow wave sleep stage 
compared to males (Briere, Forest, Chouinard, & Godbout, 2003).
Interestingly, the obesity-sleep duration relationship seems to differ by sex (Patel & Hu,
2008). While many studies have found positive associations between sleep duration and obesity 
for both sexes (Patel & Hu, 2008), the risk for obesity with short sleep duration seems to be 
higher for boys (Chaput et al., 2006; Eisenmann et al., 2006; Gibson, Lambert, & Neate, 2004; 
Knutson, 2005; Sekine et al., 2002). In the only existing study conducted in Canada, Chaput et 
al. (2006) found that while short sleep duration was positively associated with OWOB in 5-10 
year-olds for both sexes combined, stratified analyses showed that the relationship was only 
statistically significant in boys. Indeed, in a meta-analysis of 11 studies, the pooled odds ratio 
for OWOB in children and adolescents with short sleep duration was 2.50 for boys, compared to 
1.24 for girls (Chen et al., 2008). Because the effect of sleep loss on cardio-metabolic risk 
appears to be sex-specific, analyses were stratified by gender.
There are several possible explanations for why the sleep duration-obesity relationship 
seems to be modified by sex (Knutson, 2005). Compared to boys, girls may demonstrate 
unfavourable cardio-metabolic changes only with larger magnitudes o f sleep loss. Females may
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have better sleep quality as they spend more time in slow wave sleep (Briere et al., 2003). 
Further, females are more resistant to environmental stress, and have lower mortality rates in 
response to malnutrition, injury, and infectious disease (Eisenmann et al., 2006; Wells, 2000).
Socioeconomic status. Literature suggests that socioeconomic status is also a 
confounder in the relationship between sleep duration and cardio-metabolic disease. 
Internationally, research has demonstrated that lower socioeconomic status is related to poorer 
health outcomes, including indicators of cardio-metabolic risk (Marmot, 2003). Low 
socioeconomic status populations also tend to get less sleep than more affluent groups (Jarrin, 
Silverstein, & McGrath, 2009; Moore, Adler, Williams, & Jackson, 2002). Van Cauter and 
Spiegel (1999) postulate that socioeconomic status is linked to short sleep duration through poor 
housing conditions (e.g., crowded and/or unsafe housing, noise, and cold or hot temperatures) 
and increased stress and anxiety, which are also related to poor sleep. Another potential 
mechanism is related to the observation that patterns of cortisol secretion tend to be altered in 
low-socioeconomic populations (Dowd, Simanek, & Aiello, 2009; Lupie, King, Meaney, & 
McEwen, 2001). Given that high cortisol levels at night are known to cause sleep difficulties 
(Rodenbeck, Huether, Ruther, & Hajak, 2002), these alterations in cortisol secretion could affect 
sleep quality and duration.
Epidemiological research in both Canadian and international populations has examined 
socioeconomic status as a determinant of sleep duration in children and adolescents. The nature 
of the relationship between socioeconomic status and sleep duration differs from country to 
country. Internationally, the extent to which social and health policies address socioeconomic 
inequities differs significantly, and thus it is logical that the influence of socioeconomic status on 
sleep duration would likewise vary between countries.
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In a study of 183 Canadian youths aged 8-18 years, linear relationships were observed 
between socioeconomic status and each of sleep duration (r = .20), sleep quality (r = .25), and 
daytime sleepiness (r = -.25) (Jarrin et al., 2009). In an American study of children aged 2-7 
years old, McLaughlin Crabtree et al. (2005) observed that lower socioeconomic status was 
associated with impaired “sleep behaviour scores”, a composite measure of healthy sleep 
behaviours and characteristics (e.g., bedtime hour, having nightmares, daytime sleepiness). In 
contrast, other studies have not found associations between sleep duration and socioeconomic 
status. In a German study of 414 boys and girls aged 6-19 years, no significant association was 
observed between socioeconomic status and sleep duration (Hitze et al., 2009). In an Australian 
study of 591 seven-year old children, Nixon et al. (2008) also did not find a relationship between 
sleep duration and socioeconomic status.
The possibility that the association between sleep duration and cardio-metabolic 
indicators could differ at various levels of socioeconomic status is also conceivable. No research 
could be located that examined whether the relationship between sleep duration and cardio- 
metabolic risk varies at different levels of socioeconomic status. The possibility of an interaction 
effect was explored through testing of interaction terms.
Chronic conditions. Chronic health conditions could be a confounder in the 
sleep/cardio-metabolic disease relationship through a number of complex pathways. Firstly, 
symptoms associated with chronic health conditions cause sleep difficulties. For example, 
people suffering from chronic pain are more likely to report sleep disturbance (Smith & 
Haythomthwaite, 2004). Similarly, while deterioration in cardio-metabolic health may be a 
consequence of chronic sleep loss, type 2 diabetes and obesity may also play an etiologic role in 
sleep disturbance (Nieto et al., 2006). For example, type 2 diabetes induces changes in nervous
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system function which are thought to cause sleep apnea (Nieto et al., 2006). Finally, some 
medications can affect both sleep and cardio-metabolic health. For example, inflammatory 
diseases are often treated with glucocorticoid medications that, similar to the effects of 
endogenous cortisol described above, cause side-effects that include insomnia, hypertension, 
weight gain, and alterations in carbohydrate metabolism (Mayo Clinic, 2010; U. S. National 
Library of Medicine, 2011).
A complex relationship connects psychiatric disorders to sleep disturbances and cardio- 
metabolic risk factors. Patients with psychiatric disorders frequently report sleep disturbances 
(Nieto et al., 2006; Smith & Haythomthwaite, 2004; Wulff, Gatti, Wettstein, & Foster, 2010) 
including both insomnia and hypersomnia (Benca, 2008). While behavioural factors related to 
psychiatric disorders can cause sleeping problems, physiological abnormalities can also be a 
common pathogenic factor in the etiology of both psychiatric conditions and sleep disturbance 
(Benca, 2008). Some psychiatric disorders are also linked to factors leading to poor cardio- 
metabolic health. For example, night-eating syndrome and seasonal affective disorder are both 
linked to overeating and weight gain (Benca, 2008). Further, symptoms associated with 
psychiatric disorders could lead to reduced motivation and/or ability to exercise. Medications 
used to treat psychiatric disorders (e.g., selective serotonin reuptake inhibitors, antipsychotics) 
can have deleterious effects on body mass and carbohydrate metabolism (Allison et al., 1999; 
Kivimaki et al., 2010). Finally, stimulant medications used to treat attention deficit/hyperactivity 
disorder can cause sleep disturbances (Corkum, Panton, Ironside, MacPherson, & Williams,
2008; Schwartz et al., 2004).
Behaviour covariates. Knowledge of behaviours that influence sleep duration and 
cardio-metabolic risk factors is important because behaviours are potentially modifiable.
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Moreover, behaviours that independently influence cardio-metabolic risk are potential 
confounders in this study. Relationships among behaviours, sleep duration and cardio-metabolic 
risk are complicated. Behaviours may be causes or consequences of short sleep duration and/or 
cardio-metabolic risk factors. Several behaviours have been explored as covariates in the sleep- 
obesity relationship, including physical activity, TV watching, video game playing, and 
computer time.
Physical activity. Physical activity is a likely confounder in the sleep duration/cardio- 
metabolic risk relationship. While it is fairly well established that engagement in vigorous 
physical activity is related to favourable cardio-metabolic health (Yassine et al., 2009), evidence 
also suggests that exercise has an independent, favourable impact on sleep duration and quality. 
In a laboratory study of 11 children, a period of high-intensity aerobic exercise during the day 
was followed by increased time spent in deeper sleep stages (slow wave sleep) and improved 
ease of falling asleep compared to sleep after less intense exercise (Dworak et al., 2008). 
Epidemiological studies also show that physically active youth sleep better. In a study involving 
434 Swiss adolescents, teen athletes had better sleep quality, fell asleep faster, awakened less 
often during the night, and had less daytime tiredness than the comparison group (Brand et al., 
2010). In an American study, physical activity was related to decreased sleep disruption (Gupta 
et al., 2002). Similarly, cardiorespiratory fitness and physical activity are related to better sleep 
quality and longer sleep duration, respectively, in Portuguese adolescent females and German 
girls (Hitze et al., 2009; Mota & Vale, 2010). Long sleepers are also more likely to be involved 
in organized sports (von Kries, Toschke, Wurmser, Sauerwald, & Koletzko, 2002).
Additionally, vigorous physical activity improves mood and reduces stress and anxiety (Strong et
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al., 2005) which should improve sleep quality and duration (Uhde, Cortese, & Vedeniapin,
2009).
Television watching. Television watching is an independent risk factor for cardio- 
metabolic risk factors (Chaput, Klingenberg, Astrup, et al., 2010). Not only is television 
watching a sedentary activity, but television time may also increase food consumption 
independently of appetite (Blass et al., 2006; Chaput, Klingenberg, Astrup, et al., 2010). While 
largely unstudied, potential relationships between television watching and sleep duration are 
likely complex. Firstly, television watching could be a cause of sleep loss. Specifically, people 
may give up sleep in order to watch more television, or television viewing could decrease ease of 
falling asleep by having a stimulating effect. Watching television could also be a consequence of 
sleep difficulty (people watch television due to being unable to fall asleep). Finally, television 
watching could also be a reflection of an unhealthy lifestyle. Other screen-related activities such 
as video game playing and computer usage are similarly linked with sleep difficulties (Garrison, 
Liekweg, & Christakis, 2011).
Food intake. As with other covariates examined here, the connections among food 
intake, sleep duration, and cardio-metabolic risk factors are complex. Eating behaviour plays a 
role in the development of obesity, cardiovascular disease, and diabetes, and eating habits can 
also be a reflection of overall lifestyle. Further, sleep duration may also independently influence 
eating habits. As described earlier, experimental research on healthy adults demonstrates that 
chronic partial sleep deprivation results in changes in appetite-related hormones (Spiegel et al., 
1999; Spiegel, Tasali, et al., 2004) as well as in increases in subjective appetite (Brondel et al.,
2010) and more calories consumed from snacks (Nedeltcheva, Kilkus, et al., 2009).
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No experimental studies have explored the effect o f sleep loss on eating behaviour in 
children or adolescents, but epidemiological studies have explored this linkage. For example, in 
a Finnish study of 1,265 10-11 year old children, short sleep duration was related to increased 
consumption of energy-rich foods and lower consumption of nutrient-dense foods (Westerlund, 
Ray, & Roos, 2009). Similarly, Hitze et al. (2009) found that German children who were short 
sleepers were more likely to consume soft drinks and fast food. In a population of American 
adolescents aged 16-19, short sleep duration was linked to increased snacking behaviour and 
higher fat and carbohydrate intake (Weiss et al., 2010).
Other variables. This study does not account for all variables potentially related to 
cardio-metabolic disease or sleep duration. For example, other covariates in the sleep-obesity 
relationship include ethnicity, parental obesity, breastfed status, dietary habits, and substance use 
(Chaput et al., 2006; Hasler et al., 2004; Knutson, 2005). These variables are not examined in 
this study because the Canadian Health Measures Survey did not collect data on these items, or 
the variables could not be used for methodological reasons such as sample size, age range 
coverage, or missing data.
Gaps in the Literature
Based on the literature reviewed here, several knowledge gaps were illuminated, 
providing a rationale for this research. Firstly, while some international research exists on the 
relationship between sleep duration and obesity in children and adolescents, Canadian research is 
sparse. Only one study has been conducted with Canadian children, and this was a relatively 
small study restricted to Quebecois children aged 5-10 years (Chaput et al., 2006). No study has 
examined sleep duration and obesity among Canadian adolescents. Additionally, while 
experimental and epidemiological research on adults supports linkages among sleep loss,
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hypertension, dyslipidemia, and impaired carbohydrate metabolism, few studies have examined 
these relationships in children or adolescents. Only a single study with a relatively small sample 
size could be located that examined relationships between insulin resistance and sleep duration in 
a population of obese children and adolescents (Flint et al., 2007). No such research has been 
undertaken in order to explore similar relationships to other cardio-metabolic risk factors.
Finally, no study could be located that identified the determinants, or predictors, of short sleep 
duration in Canadian children and adolescents.
Study Objectives and Hypotheses
There were two main objectives of this study. Firstly, this study investigated associations 
between short sleep duration and indicators of cardio-metabolic disease in a nationally 
representative sample of Canadian children and adolescents. Secondly, this study explored 
determinants of short sleep duration in this population. To achieve these research objectives, this 
study tested two hypotheses. First, it was hypothesized that Canadian youth with short sleep 
duration exhibit greater odds of having indicators of cardio-metabolic disease, including obesity, 
dyslipidemia, and dysregulation of carbohydrate metabolism compared to longer sleepers. 
Secondly, it was hypothesized that increasing age, low socioeconomic status, low household 
education, and having a chronic condition are all associated with increased odds of short sleep 
duration.
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Chapter 2: Methods
Participants
Data for this research were obtained from the 2007-2009 Canadian Health Measures 
Survey (CHMS) (Statistics Canada, 2010b), a nationally representative Canadian population 
health survey. Further details regarding the CHMS are included in Appendix A. Inclusion 
criteria were participants aged 6-17 years old; participants with diabetes were excluded. Two 
data files were used for analyses, including the full sample (n=1690), and the fasting subsample 
that only included participants who were fasting (n=735).
Materials and Procedures
Measures.
Sleep duration. Sleep duration was gathered by self-report through the survey question 
“How many hours do you usually spend sleeping in a 24 hour period, excluding time spent 
resting?” Parents/guardians answered the question for children aged 6-11 years. Sleep duration 
was recoded from a continuous variable to a dichotomous variable (‘short sleeper’ vs. ‘not a 
short sleeper’) based on age-specific sleep requirements (Chen et al., 2008). According to Chen 
et al. (2008), children aged 6-10 years need at least 10 hours of sleep per night, and those aged 
11-17 years need at least nine hours of sleep per night. Participants who did not meet these sleep 
requirements were assigned to the ‘short sleeper’ category, while those who met sleep 
requirements were categorized as ‘not a short sleeper’.
Overweight/obesity. In the clinical exam, height and weight measurements were 
performed by trained professionals. Weight was measured with a Mettler Toledo digital scale, 
and standing height was measured with a stadiometer. From these measurements, body mass 
index (BMI) was calculated by dividing body mass (kg) by height squared (m2). The original
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CHMS variable classified participants as obese, overweight, or neither using cut-points based on 
z-scores standardized for age and sex from pooled international data (Cole et al., 2000). To 
create a dichotomous variable, the original three categories were recoded to two categories, with 
participants in either the overweight or obese categories assigned to the ‘overweight or obese’ 
category, and no change made to those originally designated as ‘neither’.
Insulin, HDL cholesterol, and triglycerides were measured using fasting blood tests. Cut- 
points for the associated dichotomous variables were established using criteria used by Lambert 
et al. (2004). The continuous insulin data were recoded into a dichtomous variable, with the 75th 
percentile designated as the cut-point for hyperinsulinemia versus no hyperinsulinemia (Lambert 
et al., 2004). For low HDL cholesterol, the 25th percentile was designated as the cut-point, with 
those falling below the 25th percentile assigned to the ‘low HDL cholesterol’ category (Lambert 
et al., 2004). The cut point for ‘high triglycerides’ was set at the 75th percentile.
Age. Age was self-reported, and was defined as the age, in years, given at the time of the 
clinical examination. In logistic regression, predictor variables must have a linear relationship 
with the outcome variable (Hosmer & Lemeshow, 2000). To meet this assumption, the age 
variable was recoded from a continuous variable to a dichotomous variable with categories for 
ages 6-11 and ages 12-17.
Sex. Sex was self-reported at the time of the clinical examination and consisted of two 
categories (male/female).
Chronic conditions. Chronic health conditions were self-reported and based on survey 
questions that probed for clinically diagnosed conditions (Table 19, Appendix A). Respondents 
with at least one chronic condition were coded as having a chronic condition. Chronic health
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conditions with the highest frequencies included ‘other’ (13.1%), asthma (11.2%), learning 
disability (8.1%), back problems (4.2%), and mood disorders (1.6%).
Education. Household education was self-reported, and was defined as the highest level 
of education achieved by any member of the household. To preserve stability of the estimates, 
the education variable was collapsed from four strata to two strata as per recommendations from 
Statistics Canada. For education, the upper-most stratum (has post-secondary degree/diploma) 
was recoded as ‘higher education’ and the bottom three strata (less than secondary, secondary, or 
some post-secondary) were assigned to the Tower education’ category.
Income. Income was self-reported, was originally a dichotomous variable (Tow income’ 
vs. ‘middle/high income’) and was not altered.
Data Analyses
Data were analyzed using the statistical software packages SPSS 20.0 and WesVar 5.1. 
Descriptive statistics were calculated to provide an overall view of the study population 
characteristics (Table 2). Initial checks were conducted to ensure that the data met the 
assumptions for the statistical tests. Statistical significance was assessed at p  < .05. In logistic 
regression models, statistical significance was assessed for the overall model (likelihood ratio 
test) and for the predictive ability of the individual variables (odds ratio with confidence 
interval). Population weights were utilized to develop nationally representative estimates. To 
account for the complex CHMS sampling design, bootstrapping was used to calculate the 
coefficient of variation and confidence intervals.
Testing for interaction terms was a two-step process recommended by Hosmer and 
Lemeshow (2000). The first step involved identifying scientifically plausible interaction terms. 
Each interaction term was then added to a bivariate logistic regression model. Interaction terms
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associated with the outcome variable with a significance level of at least p < . 10 were then added 
to multivariate models with all covariates. If the interaction term added to the predictive ability 
of the model, then it was addressed in the analyses. Models were also stratified by age and sex 
to further test for heterogeneity of effect. Although the full set of coefficients for each of the 
models is presented in tabular format throughout the results section, the interpretation of 
coefficients was restricted to key predictor variables relevant to the original research questions.
Objective 1. To examine associations between sleep duration and the four indicators of 
cardio-metabolic disease, four logistic regression models were developed. These models are 
represented in Figures 1 A-ID (Chapter 1). The first regression model included sleep duration as 
the predictor variable and OWOB as the outcome variable, with having a chronic condition, 
household education, and household income included as covariates (Figure 1 A). This model was 
tested using both the full sample and the fasting subsample. Using the fasting subsample, 
subsequent parallel regression models were tested with each of hyperinsulinemia (Figure IB), 
high triglycerides (Figure 1C), and low HDL cholesterol (Figure ID) as the outcome variable 
respectively.
Although both the full and fasting samples could have been utilized for the models 
predicting OWOB, the full sample (n=1690) was used for OWOB initially because the larger 
sample size in the full sample provided more statistical power. However, in order to compare the 
hypothesized relationships between short sleep duration and each of the different cardio- 
metabolic indicators that require the fasting sample (hyperinsulinemia, low HDL, and high 
triglycerides), the logistic regression analyses for OWOB were repeated using the fasting sample 
(n=735).
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Objective 2. To identify determinants of sleep duration, logistic regression models were 
developed, with age, sex, chronic conditions, education and income entered as predictor 
variables, and sleep duration included as the outcome variable. This model is represented in 
Figure IE (Chapter 1). Models were also stratified by age and sex to explore whether the 
predictors of short sleep duration are different for girls compared to boys, and for children 
compared to adolescents. The full sample was utilized for these regression models because the 
sample size was larger and it contained all variables necessary for the analyses.
Ethics
Several measures were taken to ensure this research project was conducted ethically, 
including following Statistics Canada policies and procedures, and ensuring the data were 
collected ethically (Statistics Canada, 2010d). To get permission to access the CHMS data, a 
proposal was submitted to the Social Sciences and Humanities Research Council of Canada 
(SSHRC) for review, which included an evaluation of threats to confidentiality, as well as the 
feasibility and utility of the research. All researchers involved in the project underwent a 
security screening check, and agreed to abide by the Statistics Act (Statistics Canada, 2010a, 
2010e). Data were accessed from within the secure Research Data Centres (RDCs) at the 
University of Victoria and the University of British Columbia. No raw data were removed from 
the RDC: only the results of analyses were removed after first being vetted by Statistics Canada 
analysts (Statistics Canada, 2010d). Numerous measures were in place to ensure that the CHMS 
data collection and storage was conducted ethically, including working closely with partners 
such as the Health Canada Research Ethics Board and the Office of the Privacy Commissioner of 
Canada (Day, Langlois, Tremblay, & Knoppers, 2007). Day et al. (2007) provide extensive 
detail regarding the ethical measures in place for the CHMS.
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Chapter 3: Results
Data Screening and Cleaning
The full CHMS sample included 1690 participants aged 6-17 years with complete data, 
and the fasting subsample had 735 participants with complete data. Characteristics of the study 
participants are documented in Table 2, including proportions and standard errors (SE).
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Table 2
Characteristics of the Study Population (Bootstrapped Data)
Full sample Fasting sample
(n=1690) (n=735)
% (SE) % (SE)
Age category
6-11 years 49.8 (0.8) 49.4(1.3)
12-17 years 50.2 (0.8) 50.6(1.3)
Sex
Male 53.0 (0.9) 53.2(1.2)
Female 47.0 (0.9) 46.8(1.2)
Sleep adequacy
Short sleeper 44.0(1.4) 44.7 (2.5)
Not a short sleeper 56.0(1.4) 55.3 (2.5)
OWOB status
OWOB 25.5 (2.2) 28.1 (2.7)
No OWOB 74.5 (2.2) 71.9(2.7)
Insulin levels
Hyperinsulinemia - 23.0(1.8)
No hyperinsulinemia - 77.0(1.8)
Triglyceride levels
High triglycerides - 23.8 (2.0)
No high triglycerides - 76.2 (2.0)
HDL levels
Low HDL - 24.7 (2.0)
No low HDL - 75.3 (2.0)
Household education
Below post-secondary 20.2 (2.7) 20.3 (3.5)
Post-secondary 79.8 (2.7) 79.7 (3.5)
Household income
Low 23.9 (2.9) 24.8 (2.8)
Middle/high 76.1 (2.9) 75.2 (2.8)
Chronic condition
Yes 30.5 (2.9) 33.0 (3.4)
No 69.5 (2.9) 67.0 (3.4)
Note. OWOB=Overweight or obese, HDL=High density lipoprotein.
Missing Data. Participants with missing data for any of the study variables were 
excluded from analyses. In the full sample, of the 1876 participants who met inclusion criteria, 
186 had missing data and were excluded, leaving a final sample size of 1690. In the fasting
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subsample, 828 participants met inclusion criteria, and 93 with missing data were excluded. 
Based on recommendations from Statistics Canada, for participants with insulin levels coded as 
below the lowest detectable limit of 14.43 pmol/L, data were imputed using the L/V2 method 
(Homung & Reed, 1990). Using the L/V2 method, the geometric standard deviation (GSD) was 
first obtained by log-transforming the insulin data then calculating the exponential value of the 
standard deviation. Because the calculated GSD was below 3.0, the lowest detectable limit for 
insulin was divided by V2 to get 10.20 pmol/L. This figure was subsequently imputed for all 
participants with insulin data coded as below the detectable limit.
Chi-square tests were performed to examine differences between participants with and 
without missing data for the full sample and fasting subsample (Table 3). In the lull sample, 
analyses indicated that participants with missing data were older, more likely to be short 
sleepers, more likely to have a chronic condition, and more likely to have low household 
education levels. The same pattern was observed in the fasting subsample, with the exception 
that education level and sleep duration did not differ according to missing data status. In the 
fasting subsample, participants with missing data were more likely to have hyperinsulinemia.
Model Building Process. During the initial data exploration process, several variables 
were eliminated from the models. Although it had been hoped that findings from the activity 
monitor data could provide information on physical activity and sleep duration, these data were 
excluded because of a large amount of missing data. Self-reported measures o f physical activity 
were different for children and adolescents, so these variables were also eliminated from the 
models.
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Table 3
Characteristics o f Participants with Complete vs. Missing Data (Bootstrapped Data)
Characteristic
Full sample (n=1876) 
Complete Missing 
(n=1690) (n=186)
Fasting subsample (n=828) 
Complete Missing
% (SE) % (SE) Pa % (SE) % (SE) P*
Age <.001 .001
6-11 years 49.8 (0.8) 21.0 (3.2) 49.4 (1.3) 31.9 (4.3)
12-17 years 50.2 (0.8) 79.0 (3.2) 50.6 (1.3) 68.1 (4.3)
Sex .305 .401
Boys 53.0 (0.9) 48.9 (3.8) 53.2(1.2) 48.8 (5.5)
Girls 47.0 (0.9) 51.1 (3.8) 46.8(1.2) 51.2 (5.5)
OWOB status .862 .257
OWOB 25.5 (2.2) 26.1 (4.9) 28.1 (2.7) 33.5 (7.6)
Not OWOB 74.5 (2.2) 73.9 (4.9) 71.9 (2.7) 66.5 (7.6)
Sleep duration <.001 .536
Inadequate 44.0 (1.4) 56.2 (5.9) 44.7 (2.5) 48.0 (8.9)
Adequate 56.0 (1.4) 43.8 (5.9) 55.3 (2.5) 52.0 (8.9)
Insulin - .001
Hyperinsulinemia - - 23.0 (1.8) 39.4 (7.8)
No hyperinsulinemia - - 77.0 (1.8) 60.6 (7.8)
Triglycerides - .111
High triglycerides - - 23.8 (2.0) 31.1 (6.9)
No high triglycerides - - 76.2 (2.0) 68.9 (6.9)
HDL - .053
Low HDL - - 24.7 (2.0) 33.7 (6.9)
No low HDL - - 75.3 (2.0) 66.3 (6.9)
Household education .004 .974
Below post secondary 20.2 (2.7) 29.7 (5.3) 20.3 (3.5) 19.7(5.1)
Post secondary 79.8 (2.7) 70.3 (5.3) 79.7(3.5) 80.3 (5.1)
Household income .109 .614
Low 23.9 (2.9) 31.7(12.4) 24.8 (2.8) 21.8 (9.4)
Middle/high 76.1 (2.9) 68.3 (12.4) 75.2 (2.8) 78.2 (9.4)
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Table 3 (continued)
Characteristics o f Participants with Complete vs. Missing Data (Bootstrapped Data)
Characteristic
Full sample (n=1876) 
Complete Missing 
(n=1690) (n=186)
Fasting subsample (n=828) 
Complete Missing 
(n=735) (n=93)
% (SE) % (SE) p a % (SE) % (SE) p a
Chronic condition .008 .628
Yes 30.5 (2.9) 39.6 (6.9) 33.0(3.4) 35.6(7.8)
No 69.5 (2.9) 60.4 (6.9) 67.0 (3.4) 64.4 (7.8)
Note. Bold=p < .05. OWOB=Overweight or obese, HDL=High density lipoprotein.
aX2 test for differences between participants with full and missing data for at least one variable.
Assumptions. The data were checked to ensure that the assumptions for the analyses 
were met. Using the 90-10 split method (Tabachnick & Fidell, 2007) no univariate outliers were 
detected. The unstratified multivariate models had adequate fit, indicating no need to search for 
multivariate outliers (Tabachnick & Fidell, 2007). No multicollinearity was identified after 
examining the standard errors and correlations among the independent variables from the logistic 
regression output. All models satisfied the minimum ratio of at least 20 cases per independent 
variable (Hosmer & Lemeshow, 2000). Although all interaction terms tested were not 
significant and thus were not included in the final models, models were stratified by age and sex 
to further examine for heterogeneity of effect and to provide estimates comparable to other 
studies.
Objective 1: To examine associations between short steep duration and indicators of 
cardio-metabolic disease.
Associations Between Short Sleep Duration and Overweight/Obesity. Based on 
CHMS data, the national prevalence of OWOB in the Canadian population aged 6-17 was 
25.5%. Characteristics of participants classified as either OWOB or Not OWOB are outlined in
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Table 4. Chi square analyses indicated that participants with short sleep duration, adolescent
age, and lower household education were more likely to be OWOB.
Table 4
Characteristics of Participants With and Without OWOB (Bootstrapped, Full Sample)
Characteristic OWOB (n=393) % (SE)
Not OWOB (n=1297) 
% (SE) P*
Sleep duration <.001
Inadequate 52.5 (2.8) 41.1 (1.7)
Adequate 47.5 (2.8) 58.9 (1.7)
Age .047
6-11 years 45.7 (2.1) 51.2 (1.5)
12-17 years 54.3 (2.1) 48.8 (1.5)
Sex .068
Male 56.8(2.1) 51.7(1.1)
Female 43.2 (2.1) 48.3 (1.1)
Household education .004
Below post secondary 25.0 (4.0) 18.5 (2.7)
Post secondary 75.0 (4.0) 81.5 (2.7)
Household income A l l
Low 25.3 (4.0) 23.5 (3.2)
Middle/high 74.7 (4.0) 76.5 (3.2)
Chronic condition .088
Yes 33.7 (3.8) 29.3 (3.0)
No 66.3 (3.8) 70.7 (3.0)
Note. Bold=p < .05. OWOB=Overweight or obese. aXl test for differences in characteristics 
among those with and without OWOB.
The results of logistic regression analyses with sleep duration as the predictor variable 
and OWOB as the outcome variable are presented in Table 5. In a bivariate logistic regression 
model with sleep duration as the predictor variable and OWOB as the outcome variable, short 
sleepers had an odds ratio of 1.59 (95% Cl 1.19-2.88) for OWOB compared to children and
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adolescents who reported meeting recommended sleep duration guidelines' In a multivariate 
model adjusting for the effect of age, sex, chronic conditions, education, and income, the odds 
ratio for OWOB in short sleepers were slightly attenuated to 1.56 (95% 0=1.15-2.19). In sex- 
stratified models, boys with short sleep had increased odds of OWOB (OR=1.85, 95% CI=1.19- 
2.88), but girls did not (OR=1.27, 95% 0=0.63-2.57). In age-stratified analyses, short sleepers 
aged 12-17 had increased odds of OWOB (OR=1.77, 95% 0=1.05-2.99) but no significant 
effect was observed in children aged 6-11 years (OR=1.37, 95% 0=0.84-2.22). Table 6 presents 
the coefficients for all variables included in the models.
Table 5
Odds Ratios For OWOB in Short Sleepers (Bootstrapped Data)
Model Modeld OR (95% Cl)
Bivariate <.001 1.59 (1.19-2.88)
Multivariate3 <.001 1.56 (1.15-2.19)
Boys multivariateb <.001 1.85 (1.19-2.88)
Girls multivariateb .007 1.27 (0.63-2.57)
Age 6-11 multivariate0 .040 1.37 (0.84-2.22)
Age 12-17 multivariate0 .001 1.77 (1.05-2.99)
Note. Bold=p < .05. OWOB=Overweight or obese
aOdds ratio adjusted for age, sex, chronic conditions, education and income. 
bOdds ratio adjusted for age, chronic conditions, education and income.
°Odds ratio adjusted for sex, chronic conditions, education and income. 
dLikelihood ratio test for significance of full models vs. constant-only models.
SLEEP DURATION AND CARDIO-METABOLIC INDICATORS 49
Table 6
Odds Ratios (95% Cl) for All Variables Included in Multivariate Models Predicting OWOB (Bootstrapped Data, Full Sample)
Predictor variable Unstratified Model3 Sex-stratified Models Age-stratified Modelsc
Boys Girls 6-11 years 12-17 years
Short sleeper 
Adolescent age 
Male sex 
Chronic condition 
Low education 
Low income 
Modeld
1.56 (1.15-2.19)
1.09 (0.78-1.52) 
0.80 (0.64-1.00) 
0.88 (0.62-1.25) 
0.68 (0.44-1.07) 
0.97 (0.59-1.62) 
<.001
1.85 (1.19-2.88)
1.11 (0.75-1.65)
0.92 (0.58-1.45) 
0.68 (0.30-1.54) 
1.41 (0.62-3.22) 
<.001
1.27 (0.63-2.57) 
1.07 (0.57-1.99)
0.86(0.54-1.38) 
0.67 (0.47-0.94) 
0.66 (0.44-1.01) 
.007
1.37(0.84-2.22)
0.87 (0.63-1.19) 
1.21 (0.73-2.01) 
0.74 (0.31-1.82) 
0.78 (0.34-1.76) 
.040
1.77 (1.05-2.99)
0.75 (0.46-1.21) 
0.70 (0.38-1.29) 
0.64 (0.34-1.22) 
1.20 (0.74-1.95) 
.001
Note. Bold=/> < .05
“Odds ratio adjusted for age, sex, chronic conditions, education and income. 
bOdds ratio adjusted for age, chronic conditions, education and income. 
cOdds ratio adjusted for sex, chronic conditions, education and income. 
dLikelihood ratio test for significance of full models vs. constant-only models.
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Associations Between Short Sleep Duration and Hyperinsulinemia. The fasting 
subsample (n=735) was used to conduct all analyses involving hyperinsulinemia, low HDL 
cholesterol, and high triglycerides. Based on the CHMS dataset, the national prevalence of 
hyperinsulinemia in the Canadian population aged 6-17 was 23.0%. Characteristics of 
participants with and without hyperinsulinemia are outlined in Table 7. Chi square analyses 
indicated that participants with short sleep duration, aged 12-17 years, with lower household 
education, or with a chronic condition were more likely to have hyperinsulinemia (Table 7).
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Table 7
Characteristics o f  Participants With and Without Hyperinsulinemia 
(Bootstrapped Data, Fasting Subsample)______________________
Characteristic (n=735)
Hyp erinsulinemia 
(n=158)
% (SE)
No Hyperinsulinemia 
(n=577)
% (SE)
a
P
Sleep duration .001
Inadequate 55.6 (4.2) 41.5 (3.2)
Adequate 44.4 (4.2) 58.5 (3.2)
Age <.001
6-11 years 23.5 (3.9) 57.1 (2.4)
12-17 years 76.5 (3.9) 42.9 (2.4)
Sex .588
Male 51.4 (3.1) 53.8 (1.3)
Female 48.6 (3.1) 46.2(1.3)
Household education .013
Below post secondary 27.0 (6.4) 18.3 (3.2)
Post secondary 73.0 (6.4) 81.7 (3.2)
Household income .278
Low 21.6(4.4) 25.7 (2.8)
Middle/high 78.4 (4.4) 74.3 (2.8)
Chronic condition .002
Yes 42.7 (7.7) 30.1 (3.5)
No 57.3 (7.7) 69.9 (3.5)
Note. Bold=p < .05 aX  test for differences in characteristics among participants 
with and without hyperinsulinemia.
In a bivariate logistic regression model with sleep duration as the predictor variable and 
hyperinsulinemia as the outcome variable, short sleepers had significantly greater odds of having 
hyperinsulinemia (OR=1.76, 95% CI=1.07-2.92) (Table 8). However, after adjusting for age, 
sex, chronic condition, education and income, short sleep duration was not significantly linked to 
increased odds of hyperinsulinemia (OR=1.27, 95% 0=0.73-2.19). Similarly, short sleep
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duration was not a significant predictor of hyperinsulinemia either in age- or in sex-stratified 
models. Table 9 presents the coefficients for all variables included in the models.
Table 8
Odds Ratios For Hyperinsulinemia in Short Sleepers 
(Bootstrapped Data, Fasting Subsample)__________
Regression Model Modeld OR (95% Cl)
Bivariate .001 1.76 (1.07-2.92)
Multivariate® <.001 1.27 (0.73-2.19)
Boys multivariateb <.001 1.36 (0.73-2.54)
Girls multivariateb <.001 1.21 (0.58-2.50)
Age 6-11 multivariate' .030 1.63 (0.87-3.06)
Age 12-17 multivariate' <.001 1.19(0.62-2.30)
Note. Bold=p < .05
aOdds ratio adjusted for age, sex, chronic conditions, education and income. 
bOdds ratio adjusted for age, chronic conditions, education and income. 
cOdds ratio adjusted for sex, chronic conditions, education and income. 
dLikelihood ratio test for significance of full models vs. constant-only 
models.
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Table 9
Odds Ratios (95% Cl) fo r  All Variables Included in Multivariate Models Predicting Hyperinsulinemia
(Bootstrapped Data, Fasting Subsample)_____________________________________________________________
Predictor variable Unstratified Model3 Sex-stratified Models13 Age-stratified Models0
________________________________________ Boys____________Girls_________6-11 years_______ 12-17 years
Short sleeper 1.27 (0.73-2.19) 1.36 (0.73-2.54) 1.21 (0.58-2.50) 1.63 (0.87-3.06) 1.19 (0.62-2.30)
Adolescent age 4.03 (2.02-8.04) 6.39 (2.16-18.89) 2.73 (1.14-6.57) - -
Male sex 1.27 (0.89-1.82) - - 2.41 (0.93-6.28) 1.03 (0.58-1.83)
Chronic condition 0.59 (0.26-1.30) 0.71 (0.31-1.59) 0.54 (0.19-1.54) 0.71 (0.30-1.67) 0.55 (0.18-1.75)
Low education 0.70 (0.31-1.58) 0.47 (0.21-1.05) 0.83 (0.33-2.10) 1.18 (0.39-3.58) 0.59 (0.20-1.75)
Low income 1.45 (0.85-2.48) 3.78 (1.14-12.47) 0.84 (0.38-1.82) 0.65 (0.24-1.74) 2.09 (0.91-4.82)
Modeld <.001 <.001 <.001 0.030 .013
Note. Bold=p < .05
aOdds ratio adjusted for age, sex, chronic conditions, education and income. 
bOdds ratio adjusted for age, chronic conditions, education and income. 
cOdds ratio adjusted for sex, chronic conditions, education and income. 
dLikelihood ratio test for significance of full models vs. constant-only models.
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Associations Between Short Sleep Duration and Low HDL Cholesterol. Based on the 
CHMS dataset, the national prevalence of low HDL cholesterol in the Canadian population aged 
6-17 was 24.7%. Comparisons of characteristics of participants with and without low HDL 
cholesterol are outlined in Table 10. Chi square analyses indicated that participants with low 
HDL were more likely to be aged 12-17 years, have lower household education and income 
levels, and were more likely to have a chronic condition compared to those without low HDL.
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Table 10
Characteristics o f Participants With and Without Low HDL 
(Bootstrapped Data, Fasting Subsample)_______________
Characteristic (n=735) Low HDL (n=160) % (SE)
No Low HDL (n=575) 
% (SE) Pa
Sleep duration .069
Inadequate 50.6 (6.9) 42.8(1.9)
Adequate 49.4 (6.9) 57.2(1.9)
Age <.001
6-11 years 32.2 (4.2) 55.0 (2.3)
12-17 years 67.8 (4.2) 45.0 (2.3)
Sex .936
Male 53.0 (4.3) 53.3 (2.5)
Female 47.0 (4.3) 46.7 (2.5)
Household education <.001
Below post secondary 30.5 (8.3) 16.9 (2.4)
Post secondary 69.5 (8.3) 83.1 (2.4)
Household income .004
Low 32.7 (5.1) 22.1 (3.1)
Middle/high 67.3 (5.1) 77.9 (3.1)
Chronic condition <.001
Yes 45.1 (8.0) 29.0 (3.3)
No 54.9 (8.0) 71.0 (3.3)
Note. Bold=p < .05. aX  test for differences in characteristics among those with and without low 
HDL. HDL=High density lipoprotein.
Short sleep duration was not a statistically significant predictor of low HDL in 
multivariate or stratified logistic regression models (Table 11). Table 12 presents the 
coefficients for all variables included in the models.
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Table 11
Odds Ratios For Low HDL in Short Sleepers (Bootstrapped, Fasting Subsample) 
Regression Model____________ Model_____________OR (95% Cl)_________
Bivariate .069 n/ae
Multivariate3 <.001 1.06 (0.58-1.92)
Boys multivariateb <.001 1.60 (0.74-3.47)
Girls multivariateb .048 0.73 (0.37-1.42)
Age 6-11 multivariate3 .014 0.89 (0.43-1.85)
Age 12-17 multivariate3 <.001 1.22 (0.55-2.72)
Note. Bold=p < .05. HDL==High density lipoprotein.
aOdds ratio adjusted for age, sex, chronic conditions, education and income. 
bOdds ratio adjusted for age, chronic conditions, education and income. 
cOdds ratio adjusted for sex, chronic conditions, education and income. 
dLikelihood ratio test for significance of full models vs. constant-only models. 
eOdds ratio not displayed because overall model was not significant.
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Table 12
Odds Ratios (95% Cl) fo r  All Variables Included in Multivariate Models Predicting Low HDL
(Bootstrapped, Fasting Subsample)______________________________________________________________
Predictor variable Unstratified Sex-stratified Modelsb Age-stratified Models0
Model3 Boys____________ Girls___________ 6-11 years_______12-17 years
Short sleeper 1.06 (0.58-1.92) 1.60 (0.74-3.47) 0.73 (0.37-1.42) 0.89 (0.43-1.85) 1.22 (0.55-2.72)
Adolescent age 2.52 (1.41-4.52) 4.37 (1.52-12.61) 1.66 (0.70-3.91) - -
Male sex 1.05 (0.54-2.02) - - 2.21 (0.88-5.56) 0.62 (0.22-1.73)
Chronic condition 0.57 (0.30-1.09) 0.47 (0.23-0.99) 0.75 (0.30-1.86) 0.55 (0.22-1.37) 0.61 (0.33-1.13)
Low education 0.58 (0.30-1.12) 0.51 (0.13-1.97) 0.70 (0.24-2.05) 0.78 (0.23-2.59) 0.50 (0.20-1.27)
Low income 0.65 (0.39-1.06) 0.59 (0.22-1.54) 0.61 (0.20-1.84) 0.91 (0.40-2.06) 0.46 (0.20-1.05)
Modeld <.001 <.001 .048 .014 <.001
Note. Bold=p < .05. HDL=High density lipoprotein. 
aOdds ratio adjusted for age, sex, chronic conditions, education and income. 
bOdds ratio adjusted for age, chronic conditions, education and income. 
cOdds ratio adjusted for sex, chronic conditions, education and income. 
dLikelihood ratio test for significance of full models vs. constant-only models.
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Associations Between Short Sleep and High Triglycerides. Based on the CHMS 
dataset, the national prevalence of high triglycerides in the Canadian population aged 6-17 was 
23.8%. Comparisons of characteristics of participants with and without high triglycerides are 
outlined in Table 13. Chi square analyses indicated that participants with high triglycerides were 
more likely to fall into the 12-17 year old age category.
Table 13
Characteristics o f  Participants With and Without High Triglycerides
(Bootstrapped Data, Fasting Subsample)________________________________________
Characteristic (n=735)
High Triglycerides 
(n=T71)
% (SE)
Not High Triglycerides 
(n=564)
% (SE)
Sleep duration .397
Inadequate 47.5 (4.1) 43.8 (2.9)
Adequate 52.5(4.1) 56.2 (2.9)
Age .001
6-11 years 38.3 (3.5) 52.9 (1.6)
12-17 years 61.7 (3.5) 47.1 (1.6)
Sex .393
Male 50.4 (3.9) 54.1 (1.5)
Female 49.6 (3.9) 45.9(1.5)
Household education .263
Below post secondary 23.3 (6.9) 19.4 (3.3)
Post secondary 76.7 (6.9) 80.6(3.3)
Household income .058
Low 19.4 (3.9) 26.4 (3.4)
Middle/high 80.6 (3.9) 73.6(3.4)
Chronic condition .070
Yes 38.6 (5.4) 31.3 (3.8)
No
- 7;..... . » , a,L  .
61.4 (5.4) 68.7 (3.8)
Note. Bold=p < .05 aXz test for differences in characteristics among those with and 
without high triglycerides.
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Short sleepers did not have increased odds of high triglycerides in multivariate models 
accounting for age, sex, chronic conditions, education and income (OR=0.99, 95% CI=0.64- 
1.53). Similarly, sex- and age-stratified models did not demonstrate any significant associations 
between sleep duration and high triglycerides (Table 14). Table 15 presents the coefficients for 
all variables included in the models.
Table 14
Odds Ratios For High Triglycerides in Short Sleepers (Bootstrapped, Fasting 
Subsample)_______________________________________________________
Regression Model Modeld OR (95% Cl)
Bivariate .398 n/ae
Multivariate3 .002 0.99 (0.64-1.53)
Boys multivariateb <.001 1.45 (0.85-2.47)
Girls multivariateb .088 n/ae
Age 6-11 multivariate0 .012 1.16(0.56-2.43)
Age 12-17 multivariate0 .112 n/ae
Note. Bold=p < .05.
aOdds ratio adjusted for age, sex, chronic conditions, education and income. 
bOdds ratio adjusted for age, chronic conditions, education and income. 
°Odds ratio adjusted for sex, chronic conditions, education and income. 
dLikelihood ratio test for significance of full model vs. constant-only model. 
eOdds ratio not displayed because overall model was not significant.
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Table 15
Odds Ratios (95% Cl) fo r  All Variables Included in Multivariate Models Predicting High Triglycerides 
(Bootstrapped, Fasting Subsample)_______________________________ _______________________
Predictor variable Unstratified Model3 Sex-stratified Modelsb Age-stratified Models3
Boys Girls 6-11 years 12-17 years
Short sleeper 0.99 (0.64-1.53) 1.45 (0.85-2.47) n/ae 1.17(0.56-2.43) n/ae
Adolescent age 1.78 (1.27-2.51) 2.15 (1.18-3.92) n/ae - -
Male sex 1.28 (0.83-1.98) - - 1.73 (0.90-3.31) n/ae
Chronic condition 0.71 (0.43-1.17) 1.00 (0.46-2.19) n/ae 0.53 (0.33-0.85) n/ae
Low education 0.83 (0.35-1.98) 0.60 (0.16-2.28) n/ae 0.56 (0.19-1.66) n/ae
Low income 1.65 (0.83-3.29) 2.67 (1.02-7.02) n/ae 0.99 (0.38-2.57) n/ae
Modeld .002 <.001 .088 .012 .112
Note. Bold=/> < .05
“Odds ratio adjusted for age, sex, chronic conditions, education and income. 
bOdds ratio adjusted for age, chronic conditions, education and income. 
cOdds ratio adjusted for sex, chronic conditions, education and income. 
dLikelihood ratio test for significance of full models vs. constant-only models. 
eOdds ratio not displayed because overall model was not significant.
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In summary, short sleepers had higher odds of OWOB (analyses conducted using the full 
sample, n=1690) but not hyperinsulinemia, low HDL or high triglycerides (analyses conducted 
using the smaller fasting subsample, n=735). To investigate whether these results may have been 
influenced by the lower statistical power that arose from the smaller fasting sample size, logistic 
regression models using OWOB as the outcome variable were repeated using the fasting sample 
(Table 16). The odds of OWOB in short sleepers were similar when conducted with the fasting 
subsample, but as expected, confident intervals were wider (e.g., unstratified multivariate model, 
OR 1.58, 95% CI=1.00-2.48) vs. the full sample (OR 1.56, 95% CI=1.15-2.19).
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Table 16
Comparison o f Odds Ratios For Indicators o f Cardio-Metabolic Disease in Short Sleepers (Bootstrapped, Fasting Subsample)
OWOB Hyperinsulinemia Low HDL High Triglycerides
Model OR (95% Cl) Modeld OR (95% Cl) Modeld OR (95% Cl) Modeld OR (95% Cl) Model
Bivariate 1.73 (1.15-2.60) .001 1.76 (1.07-2.92) .001 n/ae .069 n/ae .398
Multivariate3 1.58 (1.00-2.48) <.001 1.27 (0.73-2.19) <.001 1.06 (0.58-1.92) <.001 0.99 (0.64-1.53) .002
Boys’3 1.93 (1.04-3.56) <.001 1.36(0.73-2.54) <.001 1.60 (0.74-3.47) <.001 1.45 (0.85-2.47) <.001
Girls'3 n/ae .110 1.21 (0.58-2.50) <.001 0.73 (0.37-1.42) .048 n/ae .088
Ages 6-11° n/ae .269 1.63 (0.87-3.06) .030 0.89(0.43-1.85) .014 1.17(0.56-2.43) .012
Ages 12-17° 1.90 (0.91-3.97) <.001 1.19(0.62-2.30) .013 1.22 (0.55-2.73) <.001 n/ae .112
Note. Bold=p < .05. OWOB=Overweight or obese, HDL=High density lipoprotein. 
aOdds ratios adjusted for age, sex, chronic conditions, education and income. 
bOdds ratios adjusted for age, chronic conditions, education and income. 
cOdds ratios adjusted for sex, chronic conditions, education and income. 
dLikelihood ratio test for significance of full model vs. constant-only model. 
eOdds ratio not displayed because overall model was not significant.
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Objective 2: To identify determinants of short sleep duration.
Based on the full sample of the CHMS, the national prevalence of short sleep duration in 
the Canadian population aged 6-17 was 44.0%. Comparisons of characteristics of participants 
with and without short sleep duration are outlined in Table 17. Chi square analyses indicated 
characteristics linked with short sleep duration included being aged 12-17 years, female sex, and 
having a chronic condition.
Table 17
Characteristics o f  Participants With and Without Short Sleep Duration 
(Bootstrapped Data, Full Sample)______________________________
Characteristic (n=T690)
Short Sleep Duration 
(n=743)
% (SE)
Not a Short Sleeper 
(n=947)
% (SE)
P*
Age <.001
6-11 years 37.0 (2.0) 59.9 (1.6)
12-17 years 63.0 (2.0) 40.1 (1.6)
Sex .033
Male 50.1 (2.8) 55.3 (1.7)
Female 49.9 (2.8) 44.7 (1.7)
Household education .251
Below post secondary 18.9(3.4) 21.2 (2.6)
Post secondary 81.1 (3.4) 78.8 (2.6)
Household income .346
Low/lower middle 25.0 (2.9) 23.1 (3.2)
Upper middle/high 75.0 (2.9) 76.9 (3.2)
Chronic condition .028
Yes 33.2 (3.3) 28.3 (3.4)
No 66.8 (3.3) 71.7 (3.4)
Note. Bold=p < .05. aX2 test for differences in characteristics between sleep duration 
categories.
To further explore risk and protective factors associated with being a short sleeper, 
logistic regression analyses were performed using the full sample (n=1690). Using short sleep
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duration as the outcome variable and age, sex, chronic conditions, education, and income as 
predictor variables, five logistic regression models were developed (Table 18).
In the unstratified multivariate model, age was the strongest predictor of short sleep 
duration. Compared to children aged 6-11, teens aged 12-17 had greater odds of not meeting 
sleep guidelines (OR 2.62, 95% CI=1.88-3.66). Sex, chronic conditions, education and income 
were not significant predictors of short sleep duration. In sex-stratified analyses, age was a 
predictor of short sleep duration both in girls (OR=3.25, 95% CI=2.16-4.90) and in boys 
(OR=2.15, 95% CI=1.30-3.55). The only other significant predictor o f short sleep duration was 
low income, which, in children aged 6-11 only, was associated with lower odds of short sleep 
duration (OR=0.60, 95% CI=0.40-0.91).
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Table 18
Predictors o f  Short Sleep Duration (Full Sample, Bootstrapped Data)
Predictor variable Unstratified Sex-stratified models Age-stratified models0
model3 Boys Girls 6-11 years 12-17 years
Adolescent age 2.62 (1.88-3.66) 2.15 (1.30-3.55) 3.25 (2.16-4.90) - -
Male sex 1.30(0.90-1.88) - - 1.05 (0.72-1.53) 1.64 (0.97-2.77)
Chronic condition 0.83 (0.58-1.19) 0.78 (0.49-1.23) 0.88 (0.48-1.61) 0.94 (0.56-1.56) 0.74 (0.41-1.32)
Low education 1.34 (0.92-1.94) 1.70(1.04-2.76) 1.03 (0.61-1.74) 1.23 (0.79-1.91) 1.40 (0.74-2.66)
Low income 0.81 (0.63-1.05) 0.99 (0.70-1.41) 0.67 (0.37-1.25) 0.60 (0.40-0.91) 1.15(0.71-1.87)
Modeld <.001 <.001 <.001 .018 .004
Note. BoId=/> < .05.
“Odds ratios adjusted for age, sex, chronic conditions, education and income. 
bOdds ratios adjusted for age, chronic conditions, education and income. 
cOdds ratios adjusted for sex, chronic conditions, education and income. 
dLikelihood ratio test for significance of full model vs. constant-only model.
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Chapter 4: Discussion
Hypothesis 1: Compared to longer sleepers, short sleepers exhibit increased odds of having 
indicators of cardio-metabolic disease.
Odds of Overweight/Obesity in Short Sleepers. The first objective of this study was to 
explore associations among short sleep duration and indicators of cardio-metabolic disease, 
including a) overweight/obesity (OWOB), b) hyperinsulinemia, c) low HDL cholesterol, and d) 
high triglycerides in a nationally representative population Canadian children and adolescents. 
Age- and sex-stratified analyses indicated that Hypothesis 1 a was supported for boys and 
adolescents only. After adjusting for the effects of age, chronic conditions, education and 
income on OWOB, boys with short sleep duration had 1.85 times the odds of OWOB compared 
to boys who met sleep guidelines; the relationship was not significant in girls (OR=l .27, 95% 
0=0.63-2.57). Similarly, after adjusting for sex, chronic conditions, education and income, 
short sleepers aged 12-17 had increased odds of OWOB (OR=1.77, 95% 0=1.05-2.99); the 
relationship was not significant in children aged 6-11 years (OR=1.37, 95% 0=0.84-2.22).
As described in Chapter 1, short sleep duration may contribute to OWOB by affecting 
both energy intake and energy expenditure. Increased energy intake consequent to short sleep 
duration may occur via increased appetite as well as through increases in non-appetite regulated 
eating behaviour (Chaput, Klingenberg, & Sjodin, 2010). Short sleep duration is also associated 
with decreases in voluntary physical activity (Schmid et al., 2009), and may also be linked with 
reductions in non-voluntary energy expenditure via basal metabolic rate, non-exercise activity 
thermogenesis and the thermic effect of food (Taheri, 2006).
The finding that boys were more vulnerable to the obesogenic effect of sleep loss is 
consistent with data from other published literature (Chaput et al., 2006; Eisenmann et al., 2006;
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Gibson et al., 2004; Knutson, 2005; Sekine et al., 2002). Several theories could explain why 
boys may be more vulnerable to the obesogenic effects of short sleep duration. As explained in 
Chapter 1, from an evolutionary perspective, girls may be more physiologically resilient to 
environmental stressors such as sleep loss (Eisenmann et al., 2006; Wells, 2000). Another 
possibility is that females reach their biological maturity earlier than males and thus their 
circadian rhythms may be attuned to sleep patterns that more closely match their social 
environment. For example, the progression from childhood to adolescence is characterized by an 
inclination towards ‘eveningness’, or a preference to be awake later at night and to sleep in later 
in the morning (Crowley, Acebo, & Carskadon, 2007). As adolescents proceed into adulthood, 
this eveningness preference tends to shift back to an increased tolerance for wakefulness earlier 
in the morning and a preference for earlier bedtimes (Crowley et al., 2007). In an Italian study, 
Tonetti, Fabbri and Natale (2008) found that adolescent females reached their peak in 
eveningness circadian rhythms at an earlier age compared to males. Sex differences in sleep 
architecture may also account for this effect. Females spend more time in slow wave sleep 
compared to males (Briere et al., 2003). Because slow wave sleep plays an important role in 
human metabolism (Spiegel et al., 2009), females may require a higher threshold of sleep loss in 
order to experience a negative health impact (Eisenmann et al., 2006).
Age-stratified analyses demonstrated that the risk of OWOB in short sleepers was only 
significant in adolescents (OR=1.77, 95% 0=1.05-2.99) but not in children (OR=1.37, 95% 
0=0.84-2.22). No previous studies that calculated similar estimates could be located. A 
potential explanation for this finding is that adolescents who report not getting enough sleep had 
also been short sleepers since childhood, and subsequently had been exposed to the obesogenic 
effects of insufficient sleep for a longer time period. This theory is supported by longitudinal
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studies on children and adolescents that demonstrated that short sleepers are more likely to gain 
weight over time (Reilly et al., 2005; Snell, Adam, & Duncan, 2007; Agras, Hammer, 
McNicholas, & Kraemer, 2004).
Stratification of analyses also resulted in smaller sample sizes and, as expected, 
corresponding wider confidence intervals. While short sleepers in all age and sex strata had 
greater odds of OWOB compared to longer sleepers, the confidence intervals overlapped the null 
(1.0) for girls and children. Although some schools of thought suggest that confidence intervals 
that overlap the null should not automatically be interpreted to indicate that no association exists 
(Szklo & Nieto, 2007), a conservative approach was taken in this study and these results were 
interpreted as sleep loss being linked to OWOB only in boys and adolescents. However, because 
of the limitations associated with smaller stratified sample sizes (Szklo & Nieto, 2007), this 
inference should be considered with caution.
Odds of Hyperinsulinemia, Low HDL, and High Triglycerides in Short Sleepers.
The results of logistic regression analyses conducted on the fasting subsample did not support the 
hypotheses that short sleepers had greater odds of hyperinsulinemia, low HDL, or high 
triglycerides compared to longer sleepers. Although other studies that examined associations 
among short sleep duration and cardio-metabolic indicators other than OWOB in children and 
adolescents are sparse, a few studies have demonstrated that short sleep is linked with adverse 
cardio-metabolic health. In a population of obese children, Flint et al. (2007) found that short 
sleepers had higher fasting insulin levels. Martinez-Gomez et al. (2011) determined that 
adolescents with short sleep had higher C-reactive protein even after adjusting for obesity. Hitze 
et al. (2009) found that short sleep duration was linked to lower adiponectin in boys, and higher 
leptin, insulin, and degree of insulin resistance in girls.
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Several explanations could account for this finding of short sleepers having increased 
odds of OWOB but not of other indicators of cardio-metabolic disease. First, children and 
adolescents may need a longer exposure time to short sleep duration to develop cardio-metabolic 
risk factors other than OWOB. Longitudinal studies examining the long-term effect of short 
sleep duration on indicators of cardio-metabolic health other than OWOB are needed to test this 
hypothesis.
Another potential reason why short sleepers had greater odds of OWOB only is that, in 
children and adolescents, cardio-metabolic health might deteriorate only as a future consequence 
of OWOB and not directly because of sleep loss. For example, the increased adiposity 
associated with OWOB is thought to result in deteriorations in other indicators of cardio- 
metabolic health (Kahn & Flier, 2000). Conversely, evidence also suggests that sleep loss, 
independently of OWOB, plays a causal role in the deterioration of cardio-metabolic health 
(Flint et al., 2007; Spiegel et al., 1999). The findings from this study did not support the 
hypothesis that short sleep duration independently increases the risk of these indicators of cardio- 
metabolic disease in children and adolescents.
Another potential reason that short sleepers did not have greater odds of hyperinsulinemia 
is that alternative measures could have provided a superior assessment of the deterioration in 
carbohydrate metabolism that occur secondary to sleep loss. Sleep loss affects both insulin 
secretion (e.g., beta cell function) and insulin resistance in numerous peripheral tissues (Spiegel 
et al., 2009). This study measured serum hyperinsulinemia, which is an appropriate measure to 
evaluate insulin resistance (Kim & Reaven, 2008). However, it is possible that a measure that 
evaluates both insulin resistance and beta cell function (e.g., the homeostatic model assessment
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of insulin resistance) would have been more appropriate given that sleep loss affects both of 
these aspects of carbohydrate metabolism (Spiegel et al., 2009).
Type II error is an additional possible explanation for why this study found that short 
sleepers had greater odds of OWOB but not other indicators of cardio-metabolic disease.
Because the fasting subsample was smaller than the full sample, it was expected that the odds 
ratios for these analyses would have wider confidence intervals (Szklo & Nieto, 2007). In 
several cases, short sleepers had greater odds of having hyperinsulinemia, low HDL, and high 
triglycerides, but the confidence intervals overlapped 1.0. Even though a conservative approach 
was taken in this study, there are differing opinions on the interpretation of confidence intervals 
that overlap 1.0 (Szklo & Nieto, 2007). Because of the concerns with sample size, the inference 
that hyperinsulinemia does not arise in children and adolescents as a consequence of short sleep 
duration should be considered with caution.
To further examine the effect of sample size on statistical significance, logistic regression 
models predicting OWOB in short sleepers were conducted on both the full and fasting samples. 
In a comparison of estimates obtained from the full and fasting datasets, the odds ratios were 
similar, but as expected, the confidence intervals were consistently wider for the fasting dataset. 
For example, in the unstratified analyses the OR and 95% Cl for OWOB in short sleepers was 
1.56 (95% 0=1.15-2.19) in the full sample versus 1.58 (95% 0=1.01-2.48) in the fasting 
sample. In a few cases, confidence intervals became wide enough to result in a statistically non­
significant estimate. In full sample analyses, 12-17 year olds with short sleep had an odds ratio 
of 1.77 (95% Cl 1.05-2.99) for OWOB. When this same analysis was conducted on the fasting 
sample, the OR for OWOB was 1.90, but the 95% Cl overlapped 1.0 (0.91-3.97) and thus was 
not statistically significant. In summary, the limitations of sample size should be considered
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when interpreting the statistical significance of odds ratios from corresponding confidence 
intervals.
Hypothesis 2: Factors associated with greater odds of short sleep duration include 
adolescent age, chronic conditions, low household income, and low household education.
The second objective of this research was to identify risk and protective factors 
associated with short sleep duration. Age was the strongest predictor of short sleep duration, 
with teens aged 12-17 having greater odds of not getting enough sleep compared to children aged 
6-11. These findings are consistent with other published research that also found that age 
explained most of the variance in sleep duration, with older children more likely to experience 
sleep loss (Hitze et al., 2009; Iglowstein et al., 2003). Adolescents are less likely to meet sleep 
requirements because they restrict their sleep to meet social demands, and this reduction in 
sleeping hours surpasses the slight decline in sleep requirement that occurs in adolescence 
(Iglowstein et al., 2003).
The only other significant predictor variable was low income, which was linked with 
lower odds of short sleep duration in 6-11 year olds only. This finding was unexpected because 
previous research indicated that sleep duration is inversely related to socioeconomic status in 
Canadian children and adolescents (Jarrin et al., 2009). It is uncertain why the results of these 
studies contradict each other. A possible explanation for this finding is that children of higher 
income families are more likely to have opportunities to participate in organized activities that 
encroach on sleep time. Another possibility is that children of higher income families could have 
more technology available to them. Use of electronic devices such as cell phones, televisions 
and computers may be linked to sleep debt (Taheri, 2006). Low income was not a significant 
predictor of sleep duration in adolescents. Possibly, this finding could be explained by the
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increased independence associated with adolescence. Alternatively, it is possible that low- 
income teens might ‘catch up’ to the sleep restriction of their higher income peers by becoming 
involved in other activities that lead to sleep loss such as part-time employment.
Limitations
Validity. The potential for misclassification exists because data for several variables 
were self-reported. While it had been hoped that the CHMS activity monitor data could be used 
as an objective measure of sleep duration, an excess of missing data did not allow for this. 
Although the body of epidemiological evidence on sleep and obesity has been criticized for 
dependency on self-reported data (Bliwise & Young, 2007; Taheri & Thomas, 2008), 
comparisons of sleep duration as assessed by questionnaire and actigraphy were not significantly 
different in adolescents (Wolfson et al., 2003). However, parents may overestimate sleep length 
in younger children (Werner, Molinari, Guyer, & Jenni, 2008). Although it is unknown whether 
the magnitude of overestimation differs among parents of OWOB and non-OWOB children, no 
difference was observed among sex, age, or socioeconomic strata (Wemer et al., 2008). 
Misclassification also may have occurred because it is uncertain how closely the respondents’ 
perception of an average night’s sleep length corresponds to actual sleep length. Other self- 
reported variables that are likely to have been affected by misclassification include the 
socioeconomic status variables education and income.
Selection biases also may have influenced the results. Respondents with missing data on 
any of the study variables were excluded from the analyses. Participants with missing data were 
more likely to be short sleepers and to have hyperinsulinemia. The exclusion of these 
participants from the sample may have resulted in an underestimation of the association between 
sleep duration and indicators of cardio-metabolic disease. Biases may have also resulted from
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complete non-response. Although the survey sample was weighted to adjust for complete non­
response, weighting only ensured the sample was representative for age, sex, and geographic 
location (Giroux, 2007). Other factors that influence participation in research would not have 
been adjusted for, such as income, education level, and health status. For example, because the 
CHMS required a thorough clinical examination including fitness testing, people with chronic 
conditions that limit physical activity may have opted out of the survey. Consequently, because 
the CHMS sample was likely healthier than the actual Canadian population, the analyses 
conducted in this study may have underestimated the association between sleep duration and 
indicators of cardio-metabolic disease.
Determination of Causation. An important limitation of this study is that determining 
causation is not possible when using a cross-sectional, observational study design. One of the 
criteria for causation is that exposure to the causal factor must precede the outcome (Szklo & 
Nieto, 2007). In this cross-sectional study, it is not known whether short sleep duration preceded 
the onset of OWOB. As such, the directionality of the observed association between short sleep 
duration and OWOB is uncertain. Indeed, evidence suggests that the relationship between 
cardio-metabolic disease and sleep loss is bi-directional (Magee et al., 2010). However, 
controlled experimental studies demonstrating that sleep restriction can induce deteriorations in 
cardio-metabolic health in adults (Knutson et al., 2007) support the possibility that short sleep 
duration is an etiological factor in the development of OWOB in Canadian children and 
adolescents.
Another limitation associated with observational study designs is that confounding 
variables, and not short sleep duration, could have been causal factors in the sleep 
duration/OWOB relationship observed in this study. For example, it is possible that short
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sleepers are also more likely to engage in unhealthy behaviours linked to OWOB. Although 
multivariate models accounted for as many confounders as possible, it is likely that some 
residual confounding occurred. Similarly, models that aimed to identify predictors of short sleep 
duration could have been affected by residual confounding.
Despite the limitations associated with cross-sectional, population-based studies, there 
are several advantages to this design. First, given the existing scientific evidence linking harm to 
sleep loss, it would be unethical to intentionally subject a pediatric population to sleep 
restriction. The observational study design provides a way of measuring these associations 
ethically. Secondly, a goal of this study was to provide nationally representative estimates. 
Although controlled, experimental trials would provide strong evidence, the cost would be high 
because the required sample size to produce national estimates is large and dispersed 
geographically. The significantly lower expense of an observational study is much more 
feasible. Finally, although it is not possible to demonstrate that sleep loss is an etiological factor 
in the development of cardio-metabolic disease with this study, the results of double-blinded 
experimental studies on adults provide strong evidence that sleep loss can cause deteriorations in 
indicators of cardio-metabolic health. Moreover, the findings in this observational study support 
the findings from these controlled experimental studies. Taken together, this study and the 
corresponding body of research provide evidence that short sleep duration is a causal factor in 
the epidemic of OWOB in Canadian children and adolescents.
Disadvantages of Using the Odds Ratio. Another limitation of this study is the use o f 
the odds ratio. Although odds ratios can be considered a measure of effect size, they are often 
incorrectly interpreted to be equivalent to the relative risk (Davies, Crombie, & Tavakoli, 1998). 
When the outcome of interest is rare, this is not problematic because the relative risk and odds
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ratio are similar in value (Davies et al., 1998). However, when the outcome of interest is 
common (e.g., prevalence of more than 10%), then interpreting an odds ratio as a relative risk 
inflates the effect size of an association (Davies et al., 1998). This presents a problem for the 
present study because the prevalence of OWOB in the population was 25.5%. To address this 
issue, the relative risk for OWOB in short sleepers versus adequate sleepers was calculated and 
compared with the bivariate odds ratio. While the unadjusted odds ratio for OWOB was 1.59, 
the relative risk was calculated at 1.41. If the odds ratio had been interpreted as being equivalent 
to the relative risk (e.g., by stating that short sleepers are 59% more likely to be overweight or 
obese compared to longer sleepers), this would have inflated the actual risk of OWOB in short 
sleepers by 18%.
Despite these disadvantages, there are several advantages with using the odds ratio. First, 
a main goal of this research was to provide comparisons with other Canadian and international 
sleep duration/cardio-metabolic disease studies. Because the majority of other published studies 
used the odds ratio as a measure of association, it was advantageous to utilize this method to 
produce easily comparable results. Secondly, logistic regression models and corresponding odds 
ratios allow for the use of a dichotomous outcome variable. Dichotomous outcome variables 
were preferred because the negative health impact of indicators of cardio-metabolic disease may 
only occur at a certain threshold. For example, a high body mass index (BMI) is linked with 
health problems in the OWOB range, and not uniformly as BMI increases (Cole et al., 2000).
Alternative Statistical Approaches. Logistic regression was chosen as a measure of 
association for this study because of its ability to handle binary outcome variables, as well as to 
adjust for linear and/or categorical confounders, and also to allow for comparisons with 
previously published research. However, other methods could have been utilized, including chi-
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square analyses, linear regression, and ordinal logistic regression. Although chi-square analyses 
were used to provide a crude assessment of association, multivariate analysis was essential in 
order to account for confounding variables. Linear regression and analysis of variance would 
have allowed for the use of continuous variables, which in turn could have provided a finer level 
of detail regarding the relationship between sleep duration and indicators of cardio-metabolic 
disease. However, because the relationship between sleep duration and body mass index is not 
linear, this would have violated one of the assumptions of linear regression. Data 
transformations may have been able to satisfy this assumption, but these transformations also 
increase the complexity of interpreting the resulting coefficients (Grissom, 2000). Logistic 
regression provides the advantage of not requiring this assumption.
The ability to use dichotomous outcome variables was also advantageous because 
indicators of cardio-metabolic health are only linked with negative health implications outside of 
‘normal’ ranges (Cole et al., 2000). For example, because HDL cholesterol is linked with an 
increased risk of heart disease in the Tow’ range (American Heart Association, 2012), it is 
advantageous to examine short sleep duration’s association with low HDL, rather than with the 
HDL level expressed as a continuous variable. Although ordinal logistic regression would have 
allowed the use of additional categories linked to health risk (e.g., underweight, normal, 
overweight, obese), a larger sample size would have been required to obtain stable estimates.
Generalizability. Although the CHMS sampling strategy was designed to gain a 
nationally representative sample of the Canadian population, several populations were not 
included in the sample, including people living in institutions or on reserves, and full time 
members of the military. Institutions excluded from the CHMS include collective dwellings that 
provide custody or medical care such as boarding schools, hospitals, and group homes for youth.
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The CHMS represents approximately 96% of the Canadian population (Tremblay, Wolfson, & 
Gorber, 2007), indicating high generalizability outside of the aforementioned excluded groups. 
Future Research
The findings from this study illuminate several areas for further investigation. To build 
on the findings from this cross-sectional study, a longitudinal study could evaluate whether over 
time, short sleep duration predicts the development 'ofOWOB~and- other indicators of cardio- 
metabolic disease. As well, increased understanding of the mechanisms that lead to OWOB in 
short sleepers is needed. For example, further study of the behavioural and physiological 
consequences of sleep loss and their corresponding connection to indicators of cardio-metabolic 
disease is needed. Further study into the mechanisms underlying sex differences in the sleep 
duration-OWOB relationship is also needed. Finally, the development, implementation and 
evaluation of health promotion strategies that facilitate healthy sleep habits in children and 
adolescents should be undertaken.
Conclusion
In summary, inadequate sleep duration was linked with greater odds of OWOB in boys 
and adolescents. Short sleepers did not have increased odds of other cardio-metabolic disease 
indicators, including hyperinsulinemia, low HDL, and high triglycerides. Age predicted 
inadequate sleep duration in both sexes and all age groups. Public health strategies that 
emphasize healthy sleeping habits in children and adolescents should be trialed and assessed for 
their affect on OWOB, especially in boys. Finally, because the progression from childhood to 
adolescence is characterized by a greater risk of inadequate sleep, health promotion strategies 
that aim to address this issue should focus on addressing the factors that affect the sleep duration 
of adolescents specifically.
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Appendix A: Methodological Details - Canadian Health Measures Survey
Unless otherwise specified, all methodological detail for the CHMS presented here was 
drawn from Statistics Canada documentation (Statistics Canada, 2010b).
Sampling Strategy
All Canadians between the ages of 6-79 were potentially part o f the CHMS sample 
except for full-time members of the military, residents of institutions, and people living on Indian 
reserves or crown lands. The CHMS is representative of 96% of the Canadian population 
(Tremblay et al., 2007). To achieve a representative sample, 10 age-gender groups with a 
minimum of 500 participants per group were developed, making a total of 5,000 participants.
For the clinical exam, 257 potential clinic sites across Canada were established. Of these 
locations, 15 sites were selected using a systematic sampling method, with probability 
proportional to the population of the region. Initial contact was made through a letter mailed to 
households requesting their participation in the study.
Response Rate
From 8,772 households contacted, 69.6% provided consent to participate. Out of the 
households that agreed to participate, 88.3% responded to the household survey, and 84.9% of 
survey respondents proceeded to complete the clinical exam. The overall response rate was 
51.7% (Giroux, 2007). Weighting was used to account for non-response.
Weighting
The CHMS dataset included a weighting variable in order to calculate nationally 
representative estimates. Each person in the sample was assigned a weight, or number of other 
Canadians that he or she represented. Use of these weights in SPSS presents a problem because 
SPSS calculates weighted estimates based on the population size, and not the sample size.
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Because estimates are erroneously based on the much larger population size, SPSS will 
incorrectly indicate that calculated estimates are significant (Hahs-Vaughn, 2005). To avoid this 
problem, ‘normalized weights’ were created by dividing the weighting variable by the mean of 
the weights (Hahs-Vaughn, 2005).
Bootstrap Method
Because the CHMS sampling design involved clustering and stratification, the calculated 
sample variance is likely to underestimate the actual population variance. For example, clinical 
exams were conducted at only 15 sites across Canada, and respondents within each site are likely 
to be more similar to each other than to respondents from other locations. In order to account for 
this design effect, the survey bootstrap method can be used to better estimate the variance in the 
population (Phillips, 2004). The bootstrap method is a resampling procedure in which many 
subsamples are created from the original sample with replacement. Bootstrap weights are 
created to represent the probability of selection into the subsample (Phillips, 2004). Statistics 
Canada provides 500 bootstrap weight variables for the CHMS which were used in the program 
WesVar 5.1. The desired estimates are then recalculated using each new subsample, and the 
variance between the estimates provides a more accurate assessment of variance.
Covariates
Age. The CHMS sample population included participants aged 6-79 years. As the goal 
of this research is to examine the impact of sleep duration on cardio-metabolic risk in children 
and adolescents, the population selected for this purpose was 6-17. Adolescents aged 18 and 19 
were excluded because many variables of interest were only available for ages 6-17 (i.e., Cole’s 
BMI classification, HWMDCOL).
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Age was collected twice in the CHMS: once during the household questionnaire 
(DHH_AGE) and again at the time of the clinical exam (CLCAGE). Because of a time delay 
between the two components, age could change between the questionnaire and clinical exam. 
Thus, for accuracy, it is necessary to use the clinical exam age when examining clinical exam 
variables (i.e. blood tests), and questionnaire age when utilizing questionnaire variables (i.e. 
sleep duration). In the situation where both the household questionnaire and clinical exam data 
are used, Statistics Canada suggests using the age variable for the module containing the most 
important variable of interest. Because the outcome variables for this research are all based on 
the clinical exam portion, the age variable selected was age at the time of the clinical exam 
(CLCAGE).
Chronic conditions. As described previously, chronic illnesses are related to sleep 
disturbances (Nieto et al., 2006; Smith & Haythomthwaite, 2004; Wulff et al., 2010). During the 
household interview, participants were asked if they had ever been diagnosed with various 
chronic conditions. From the responses to these questions, the variable CCCF1 was derived 
from the answers to these questions; respondents were coded as “has at least one chronic 
condition” or “has no chronic conditions”. Constituent questions and frequencies are listed in 
Table 19.
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Table 19
Chronic Conditions Frequencies
Age Full Fasting
Survey Question range Sample Subsample
CCC 11 Do you have asthma? all 11.2% 12.5%
CCC 21 Do you have fibromyalgia? 12+ suppressed suppressed
CCC."22 Do you have arthritis or rheumatism, excluding 
fibromyalgia?
12+ suppressed suppressed
CCC..24 Do you have back problems, excluding 
fibromyalgia and arthritis?
12+ 4.2% 3.1%
CCC 31 Do you have high blood pressure? 12+ suppressed suppressed
CCC.[34 Have you ever been told by a health professional 
that your blood cholesterol was too high?
12+ suppressed suppressed
CCC 41 Do you have chronic bronchitis? all suppressed suppressed
CCC 51 Do you have diabetes? all suppressed suppressed
CCC 61 Do you have heart disease? all suppressed suppressed
CCC 71 Do you have cancer? all suppressed suppressed
CCC "81 Do you suffer from the effects of a stroke? 12+ suppressed suppressed
CCC "82 Do you have a thyroid condition? 12+ suppressed suppressed
CCC..83 Do you have a mood disorder such as depression, 
bipolar disorder, mania or dysthymia?
all 1.6% 2.5%
CCC 84 Do you have a learning disability? all 8.1% 8.3%
CCC._91 Do you have an eating disorder such as anorexia 
or bulimia?
all suppressed suppressed
CCC 92 Do you suffer from kidney dysfunction or disease? 12+ suppressed suppressed
CCC. 93 Do you have liver disease or gallbladder 
problems?
12+ suppressed suppressed
CCC 95 Do you have hepatitis? 12+ suppressed suppressed
CCC."101 Do you have any other long-term physical or 
mental health condition?
all 13.1% 14.6%
Note. Suppressed data are not displayed due to Statistics Canada minimum cell size 
requirements.
